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Abstract  
Tuberculosis (TB) is a curable disease, but continues to kill and remains a major health problem 
because of its high mortality rate throughout the world.  While infection with the causative agent, 
Mycobacterium tuberculosis (M.tb) is necessary for the development of TB, it is not sufficient to 
cause disease in most infected individuals.  
 
Only approximately 5-15% of infected, immunocompetent individuals progress to active clinical 
disease whereas the remainder will never develop the disease.  The precise factors associated with 
progression to clinical disease are still largely uncharacterized.  However the involvement of host 
genetics in TB has been proven unequivocally and, in concert with environmental factors and the 
causative bacterium, can influence the outcome of disease.  Natural killer (NK) cells are important in 
the innate and adaptive system and are regulated by two receptor superfamilies with one of those 
being the immunoglobulin-like superfamily (killer immunoglobulin-like receptors).  
 
An investigation of the role of killer immunoglobulin-like receptors (KIRs) in TB susceptibility found 
that an overexpression (≥ 5) of the activating killer immunoglobulin-like receptors (aKIRs) offers 
protection against developing active TB disease.  In the present study the aim was to compare the 
efficiency of mycobacterial killing of NK cells of individuals with five or more aKIRs versus 
individuals with less than five aKIRs.   
 
The KIR genotypes of 30 individuals were determined using a PCR sequence-specific primers 
method.  Five individuals with less than five aKIRs (group 1) and five individuals with five or more 
aKIRs (group 2) were identified.  Peripheral blood mononuclear cells (PBMCs) were isolated from 
whole blood using density gradient centrifugation. NK cell populations were isolated from the 
PBMCs through negative selection.  The NK cells were stimulated with M.tb H37Rv at two time 
points (1 hour & 24 hours), either with or without interleukin-2.  CFU counts were used to determine 
the mycobacterium’s viability.  No statistical significant difference was observed between the two 
groups (p = 0.60).  
 
The levels of cytokine production from NK cells following the stimulations were determined by 
Luminex immunoassays.  A higher expression of interferon-gamma (IFN-γ), perforin, interleukin-
17A (IL-17A) and regulated on activation, normal T cell expressed and secreted (RANTES) was 
observed for group 2.  However only RANTES expression was statistically significant (p = 0.04).  
This pilot study was the first to contribute towards a protocol to determine the killing efficiency of 
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NK cells against fighting TB infection while incorporating the KIR genotype.   Furthermore this study 
is also one of few that investigated the direct and extracellular killing of M.tb H37Rv.  
Future work includes using different techniques to determine mycobacteria viability as well as 
incorporating the HLA genotypes.  Ligand recognition assays can also be used to determine the 
involved ligand specificity.  In the long run this can be used to manipulate NK cells to generate an 
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Opsomming  
Tuberkulose (TB) is 'n siekte wat genees kan word; tog eis dit steeds menselewens en bly dit een van 
die grootste gesondheidsprobleme wêreldwyd as gevolg van die hoë sterftesyfer.  Hoewel infeksie 
met die patogeen Mycobacterium tuberculosis (M.tb) nodig is vir die ontwikkeling van TB, is dit 
alleen nie genoegsaam om die siekte by die meeste geïnfekteerde individue te veroorsaak nie.  
 
Slegs ongeveer 5-15% geïnfekteerde, immuunbevoegde individue ontwikkel die kliniese aktiewe 
toestand van die siekte, terwyl die res nooit die aktiewe siekte kry nie.  Die presiese faktore wat die 
progressie van die siekte veroorsaak, is nog nie vasgestel nie.  Die betrokkenheid van gasheergenetika 
in TB speel egter onteenseglik 'n rol en, saam met omgewingsfaktore en die oorsaaklike bakterie, 
beïnvloed dit die uitkoms van die siekte.  Natuurlike doderselle (NK) speel ‘n belangrike rol in die 
immuunsisteem en word deur twee reseptor superfamilies gereguleer, waarvan een die 
immunoglobulienagtige superfamilie is (witbloed immunoglobulienagtige reseptore).  
 
'n Ondersoek na die rol van witbloed immunoglobulienagtige reseptore (KIRs) in TB vatbaarheid het 
aangedui dat individue wat vyf of meer aktiverende immunoglobulienagtige reseptore (aKIRs) gehad 
het, minder geneig was om aktiewe TB te ontwikkel.  Hierdie studie se doel was om die effektiwiteit 
van mikobakteriële doding deur NK-selle van individue met vyf of meer aKIRs te vergelyk met 
individue met minder as vyf aKIRs. 
 
Die KIR genotipe van 30 individue is bepaal deur die gebruik van ‘n PCR sekwensspesifieke metode.  
Vyf individue met minder as vyf aKIRs (groep 1) en vyf met vyf of meer aKIRs (groep 2) is 
geïdentifiseer vir verdere studies.  Periferale bloed mononukleêre selle (PBMCs) is geïsoleer vanuit 
bloed, deur die digtheidsgradient sentrifugasie metode.  
 
NK-selle is deur negatiewe seleksie geïsoleer vanuit die PBMCs.  Die NK-selle is met M.tb H37Rv 
gestimuleer (1 uur & 24 uur), met of sonder interleukin-2.  CFU-tellings is gebruik om die 
mikobakterieë se lewensvatbaarheid vas te stel.  Geen beduidende verskil tussen die twee groepe is 
waargeneem nie (p = 0.60). 
 
Vlakke van sitokienproduksie deur NK-selle na stimulasie, is deur Luminex immunoanalise 
vasgestel.  Daar was 'n hoër uitdrukking van interferon-gamma (IFN-γ), perforien, interleukin-17A 
(IL-17A) en RANTES deur groep 2.  Slegs die verskil in RANTES uitdrukking was statisties 
beduidend (p = 0.04).  Hierdie navorsing was die eerste om by te dra tot ‘n protokol om vas te stel 
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wat die doodmaaksukses van NK-selle is as manier om TB-infeksie te beveg terwyl die KIR genotipe 
geïnkorporeer word.  Hierdie studie is ook een van net 'n paar wat die direkte en ekstrasellulêre 
doodmaak van M.tb H37Rv ondersoek.   
 
Toekomstige werk sluit die gebruik van ander tegnieke in om vas te stel wat die lewensvatbaarheid 
van M.tb is.  Die HLA genotipes van die individue moet ook geïnkorporeer word.  Ligand spesifisiteit 
kan ook bepaal word en dit kan gebruik word om NK-selle te manipuleer om die immuunsisteem te 
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Chapter 1: Introduction  
 
1.1 Tuberculosis  
Tuberculosis (TB) is a curable disease, but continues to kill and remains a major health problem 
because of its high mortality rate throughout the world1.  In one of the earliest descriptions of TB, 
Greek physician Clarissimus Galen describes TB as an ulceration of the lungs, chest or throat2.  It has 
now been established that TB is an infectious disease that is caused by the Mycobacterium tuberculosis 
(M.tb) complex (MTC)2.  This complex consists of closely related bacterial species, namely, M.tb, M. 
bovis, M. africanum, M. bovis Bacillus Calmette-Guérin (BCG), M. microti, M. canetti and M. 
pinnipedii3–6. M.tb is a rod shaped, non-spore forming, obligatory aerobic pathogen that has a 
predilection for the lung tissue which is rich in oxygen supply and thus M.tb largely causes pulmonary 
TB (PTB) in humans7–9.  Necrotising granulomatous inflammation, usually observed in the lung (~85% 
of cases), is therefore a pathological characterisation of TB7.  
 
During the infection period (between onset cough & initiation of treatment) transmission is known to 
occur, thus it would be ideal if people experiencing TB symptom would be promptly identified and 
diagnosed10,11.  Transmission occurs through the expulsion of an airborne droplet nuclei from infected 
individuals that contains viable bacilli through coughing, sneezing or talking in close proximity12.  The 
bacillary load, duration and proximity of exposure will have an influence on the transmission13.  The 
symptoms of TB are mainly, night sweats, fever, weight loss and persistent, non-remitting cough14. 
 
1.2 Global epidemic  
TB is one of the main causes of death due to a single infectious agent worldwide15,16 .  The World 
Health Organization (WHO) already declared TB a global health emergency in 1993.  Even though 
there was a 22% decrease in TB deaths between 2000 and 2015, the disease was still one of the top 10 
causes of death worldwide in 20151. TB is a significant health problem globally with developing 
countries being the most affected as indicated in figure 1.11.  In 2016 more than 10 million people fell 
ill with TB and 1.7 million died with 95% of these deaths occurring in low and middle income 
countries17.  Developed countries such as the United States and Australia have a TB incidence of less 
than 10 per 100 000 whereas the incidence of TB in developing countries like South Africa and 
Swaziland exceeds 1000 per 100 0001.  The six countries that accounted for 60% of the new TB cases 
in 2015 were India, China, Nigeria, Indonesia, Pakistan and South Africa15.  
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Figure 1.1: The estimated TB incidence rates in 2015.  Developing countries have a higher incidence of new 
cases per 100 000 than developed countries.  Adapted from World Health Organization Global Tuberculosis 
Report, 20161.  
 
1.3 Influence of TB in South Africa   
One of the countries with the highest TB incidence and subsequent mortality rates in the world is South 
Africa, with the human immunodeficiency virus (HIV) pandemic having a detrimental effect18,14.  In 
2015, the three districts with the highest TB burden were KwaZulu-Natal (KZN), Western Cape (WC) 
and  Eastern Cape (EC) (Figure 1.2)19.  In the WHO African region the proportion of TB cases living 
with HIV were 31% and exceeded 50% in some parts of Southern Africa1.  HIV is an encumbrance to 
lowering the national TB incidence rate since it increases the lifetime-risk of converting from sub-
clinical infection to active disease from 1 in 10 to 1 in 320.  In 2013, it was estimated that 10.4 million 
people had TB-HIV co-infection which was about 13% of the global incident caseload, with 80% of 
these causes occurring in Africa7 and in 2015 it was also found that 35% of HIV deaths were due to 
TB17 . 
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Figure 1.2: Incidences of TB in nine South African provinces.  Eastern Cape (EC), Kwazulu-Natal (KZN) and 
Western-Cape (WC) had the highest incidence. Adapted from District Health Barometer, 201619. (FS, Free 
state; GP, Johannesburg ; LP, Limpopo province; MP, Mpumalanga; NC, Northern Cape; NW, North West).  
 
1.4 Susceptibility to TB  
Only 5-15% of infected, immunocompetent individuals progress to active clinical disease whereas the 
remainder will never develop the disease21.  The precise factors associated with the progression to 
clinical disease is still largely uncharacterized8,22.  A key question that remains unanswered is why the 
majority of infected individuals stay healthy23.  Overall, one-third of the world’s population is infected 
with M.tb without displaying any symptoms, this group of individuals are described as latently 
infected24.   Latent TB infection (LTBI) refers to the condition in which M.tb remains viable in the 
macrophage without a large amount of metabolic activity, infected individuals remain free of 
symptoms and tissue damage18,25.  Once infected the individual is at highest risk for developing the 
disease within two years26.   
 
Other possible outcomes after M.tb infections are also known, namely (1) fail to register an infection, 
(2) become infected but then clear the infection, or (3) immediately progress to active disease.  These 
outcomes were illustrated in 1926, in Lübeck, Germany when the same live dose of virulent M.tb was 
accidentally given to 251 infants within the first 10 days of their life.  Forty seven of these children  
showed no evidence of active TB disease, 77 died and 127 had radiological signs of disease27–29.  The 
wide range of responses after M.tb infection  is one of the aspects that contributes to the distinctiveness 
of this infectious disease30.   
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There are vast differences between diverse populations with regards to TB susceptibility which adds 
to the complexity of the disease.  These differences can be due to various reasons31.  Factors that 
contribute to the variation among populations and the magnitude of risk includes lifestyle, economic 
status, HIV infection, diabetes, occupational exposure and immune-suppressive therapy7,23,28,32,33.  In 
addition to these,  the virulence of the causative organism and the genetic makeup of the infected host 
influences the progression from infected status to active disease23.  
 
1.4.1 TB and host genetics  
 
Before Koch discovered the causative bacterium, the initial belief was that TB was an inherited 
disorder.  Subsequent inquests into TB disease aetiology revealed a very complex and multifactorial 
disease since disease susceptibility is influenced by environmental, host and pathogen factors34 (Figure 
1.3).  It has also been established that human genetics contributes greatly to TB susceptibility and the 
estimated heritability range from 36% to 80%35–38.  Various twin studies indicated that monozygotic 
twins (essentially identical in their genetic makeup) showed higher concordance for the development 
of TB than dizygotic twins35,39,40 as well as a higher concordance in terms of their cellular immune 
response37. Additional compelling evidence from several case-control association studies, animal 
models of disease, whole-genome linkage scans and genome-wide association studies (GWAS), 
substantiate the involvement of human genetics in TB susceptibility41.  
 
Genetic susceptibility studies of TB are complex, since TB disease does not follow a Mendelian 
inheritance pattern and two genomes, the bacterium and the host, as well as the environment contribute 
to the outcome41.  Family-based linkage studies and population-based case-control studies indicate that 
TB susceptibility in the general population is the result of a large number of genes that are inherited in 
a complex manner which makes genetic studies more convoluted42,43.  The genes that are associated 
with active disease is not necessarily the same as those that contribute to infection risk, but play a role 
in course of disease and risk of disease development44. 
 
Numerous gene polymorphisms that influence host TB susceptibility in the general population have 
been identified, indicating the polygenic nature of the disease45–48.  An improved understanding of how 
the host-genetic make-up differs between individuals who remain healthy and those who develop active 
TB disease can possibly lead to the identification of genes and variants that can help explain these 
varying outcomes.   
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Figure 1.3: The various factors that have an effect on the outcome of infection with M.tb. Adapted from 
Casanova et al. 200234.  
 
1.5 Host immune response  
The human body is constantly invaded by a wide range of microbes, including bacteria, fungi, viruses 
and parasites.  Healthy individuals protect themselves against the replication and spread of these 
various microbes by means of their immune system.  The host immune response plays an important 
role in the outcome of TB infection and its components are encoded for by host genes22.  It is thought 
that the human factors governing whether an individual will progress to active disease or not are 
assumed to be those regulating the immunological state of the host41.  Currently it is not known which 
immune system genes regulate an individual’s disease outcome following exposure49.  The immune 
system can be divided into two parts known as innate and adaptive immunity and host protection 
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1.5.1 Innate immune response  
 
The skin acts as the first line of defence, which is impermeable to microbes if intact.  Additional non-
specific defence mechanisms responsible for repelling most infectious agents include, lysozymes,  
stomach acids or entrapment in the sticky mucous of the throat or nose51.  The innate immune system 
is the next line of defence if infectious organisms manage to penetrate the first line defences.  This 
system does not require memory in order to prevent spreading of microbes and is important in 
establishing host-pathogen interactions18.  
 
Innate immunity is non-specific and pathogens are identified when antigen presenting cells (APCs) 
recognize pathogen associated molecular patterns (PAMPs) via membrane associated pattern 
recognition receptors (PRRs), such as toll-like receptors, mannose receptors and cluster of 
differentiation (CD) 14 receptors (Figure 1.4)52,53.  After recognition these cells take up the bacilli and 
this results in activation of signalling pathways which leads to production of predominantly pro-
inflammatory cytokines52,53.  These cytokines subsequently activate lymphocytes to mount immune 
and inflammatory responses (Figure 1.4).  The innate system is thus responsible for engulfing and 
destroying the bacilli during the process of phagocytosis54. This system requires a variety of 
independent cellular responses from many different host immune cell types including macrophages, 
neutrophils, dendritic cells (DCs) and natural killer (NK) cells55.  Persistent microbes that are not 
destroyed by the innate immune system will activate the adaptive immune system.  
 
1.5.2 Adaptive immune response 
 
Adaptive responses differ from the innate immune system since they are specific and develop slowly 
on first exposure to a new pathogen51.  An essential feature of adaptive immunity is its ability to obtain 
a long lasting protection, which leads to a quicker response during subsequent exposure.  The adaptive 
immune system is classified into two broad classes known as the humoral response and cell-mediated 
immune response54.  Both of these involve T helper (Th) lymphocytes that are produced by Th1 and 
Th2 maturation pathways56 (Figure 1.4).  During the humoral responses, B lymphocytes gets activated 
to secrete antibodies which will circulate in the bloodstream and bind to foreign antigens (substance 
that is capable of eliciting an adaptive immune response) which then stimulates the production of 
antibodies51.   
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Figure 1.4: An overview of the immune response to M.tb.   Antigen-presenting cells (APC) such as DCs and 
macrophages takes up the bacilli and produce cytokines.  This activates lymphocytes that mount immune and 
inflammatory responses resulting in M.tb infection control.  Adapted from Meya & McAdam, 200748.  
 
The primary adaptive immune response to M.tb infections is cell-mediated immunity and T 
lymphocytes plays an important role in this response57.  Protective cell-mediated immunity against 
M.tb is associated with the development of Th1 responses together with the production of Th1 
cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α) and interleukin-2 
(IL-2).  The release of other cytokines like IL-4 leads to the development of Th2 responses which 
supports B lymphocyte growth and differentiation58.  While the Th1 cells direct the cell-mediated 
immunity, the Th2 cells drive the humoral immunity through up-regulation of antibody production as 
depicted in figure 1.4.  Although T lymphocytes mainly target intracellular microbes, the up-regulation 
of antibodies during the humoral response is important to recognise extracellular microbes and to 
prevent invasive pathogens.  The cells of the innate system are still very important in the adaptive 
system, specifically acting as APCs and setting the stage for the adaptive response54.   
 
NK cells are important in both the innate and adaptive immunity and forms a bridge between the two 
systems.  They are employed when cells experience various forms of stress and are known as effector 
cells of innate immunity59,60.  Even though NK cells are seen as part of the innate immune system, they 
Stellenbosch University  https://scholar.sun.ac.za
  Chapter 1: Introduction 
Page | 8  
 
display features of adaptive immune cells59,61.  There are four phases in the adaptive immune response 
against infections and the first one is known as the expansion phase.  During this phase the naïve T 
lymphocytes proliferate to mediate effector functions62–64.  The three other phases are known as 
contraction -, memory maintenance- and the recall response phase61,65–67.  It has been shown that NK 
cells undergo all four of these phases.  NK cells also functions in synchronicity with other cells of the 
immune system and are important in setting the stage for an appropriate adaptive immune response, 
for example through their interactions with DCs68,69. 
 
1.5.3. NK cells and their interactions with other immune cells  
   
1.5.3.1 NK and DCs  
Dendritic cells link the innate immune sensing of the environment to the initiation of adaptive immune 
responses.  The cross talk between this cell type and NK cells have been well documented and in the 
context of mycobacterial infections, NK cells enhance DC maturation69,70,71.  Maturation can be further 
enhanced by the production of IFN-γ and TNF.  IL-15 recognition on DCs triggers a molecular program 
which leads to NK cells lytic activity72.  DCs act as the main APC to prime naïve T cells to mount a 
suitable adaptive response to pathogens59.  It also appears that NK cells discriminate between infected, 
uninfected or improperly activated DCs73 which then act as a mechanism to control quality and 
intensity of antigen presentation during an infection74.  DC-NK interactions occur in vivo at the site of 
inflammation and it is thought that following M.tb infection, NK cells are recruited to the lung from 
peripheral blood (PB).  Therefore these cells participate in the early immune response to the pathogen 
by selecting the most suitable DC for migrating to the lymph nodes74, which contributes to optimizing 
the phase of antigen loading.  
1.5.3.2 NK and T cells  
The activity of different T cell subsets can be positively or negatively regulated by NK cells75.  For 
example, the proliferation of the gamma-delta (γδ) T cell subset seems to be dependent on the 
production of cytokines as well as direct contact between these cells and NK cells76.  Additionally, the 
depletion of NK cells in peripheral blood monocytes (PBMCs) from healthy tuberculin responders 
impaired the ability of CD8+ T cells to lyse M.tb infected monocytes and reduced the frequency of 
CD8+ T cells producing M.tb specific IFN-γ77.  The immunoregulatory effect of NK cells also extends 
to another subset of T cells, known as the T regulatory cells (Treg).  These cells are present in the blood 
and at the site of disease in patients with TB78.  The frequency of these cells in the pleural fluid 
correlates inversely with local M.tb-specific immunity79.   
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It is therefore possible that NK cell control of M.tb specific Treg expression could contribute to reduce 
Treg suppression of affected immune responses.  These studies points toward a potential role of NK 
cells in regulating multiple aspects of the immune response against M.tb infections.  It is also possible 
that NK cells are involved in the maintenance of the balance between the effector and regulator arms 
of the antigen specific immune response because of the fact that it positively regulates CD8+ and γδ+ 
T cell functions, while supressing Treg cells.  Dissecting the immune system of the host is complex 
and goes beyond the scope of this thesis, which will mainly focus on NK cells.  
 
1.6 Natural Killer (NK) Cells  
1.6.1 Characteristics  
 
NK cells are bone-marrow derived lymphocytes and comprise 5-10% of  PB circulating lymphocytes, 
however this percentage can vary with age80,81.  These cells are a heterogeneous population since they 
consist of different subsets with distinct phenotypes, tissue localization (NK cells are also found in the 
spleen, liver and lungs82) and functional activities83.  NK cells are larger than resting lymphocytes and 
phenotypically defined as CD56+ CD3-  in human peripheral blood84.  CD16, which is a receptor for 
Immunoglobulin G (IgG), also known as FcγIII, is commonly used to identify NK cells85,86.  Neural 
cell adhesion molecule (NCAM or CD56) is also expressed on NK cells, but is not as widely 
expressed87.  
 
Together CD16 and CD56 forms the characteristic markers of NK cells and these cells can be 
subdivided into different populations based on the expression of the two surface markers83.  Two major 
subsets are CD56brightCD16dim and CD56dimCD16bright. The major circulating subset is 
CD56dimCD16bright  since this subset represents at least 90% of all peripheral blood NK cells83.  The  
CD56dimCD16bright   subset is mostly known as “mature” NK cells, however it still remains controversial 
whether these subsets represent different maturational stages of NK cells or are terminally 
differentiated populations88,89.  NK cell maturation and receptor expression profile is depicted in figure 
1.5.  The “immature” NK cells are more enriched in lymphoid tissues and at sites of inflammation73. 
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Figure 1.5: Maturation profile of human NK cells, representing the major NK cell markers. Adapted from 
Chanvillard et al. 201390. pNk, precursor NK cells; iNK, immature NK cells; mNK, mature NK cells.  
 
1.6.2 Functions  
 
In 1975, Hans Wigzell and co-worker’s established that a leukaemia cell line could be lysed by cells 
that had the morphology of small lymphocytes but lacked T- and B-cell characteristics91.  This was the 
first known report on NK cells92.  The capacity of  NK cells to kill target cells and their expression of 
FcγIII receptors was demonstrated there after by Herberman and colleagues93.  It was known that NK 
cells are also active against virus-infected cells94, but the confirmation of NK cell activity against 
bacterial infections was only confirmed much later92.  The first report demonstrating this NK cell 
function showed that these immune cells could lyse Shigella flexneri–infected HeLa cells95, Legionella 
pneumophila–infected monocytes96 or M.tb–infected monocytes97.  NK cells do not show germ-line 
receptor rearrangement and the effector functions of these cells are controlled through an extensive 
repertoire of activating and inhibitory receptors.  
 
The effector functions of the cells vary depending on the cellular microenvironment98.  Although NK 
cells were first identified for their ability to kill tumour cells without activation, it is now known that 
these cells have various other functions99.  A primary role of NK cells is to provide early protection 
against infectious agents while the adaptive immune system is activating100.  This elimination of 
infectious agents is beneficial to the host since it prevents exaggerated adaptive immune responses that 
could lead to immunopathology101.  
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The mechanisms through which NK cells protect against bacterial infections are not extensively 
characterized and only a few studies have investigated the roles of NK cells in bacterial infections of 
the lung102.  The role of NK cells against infections can be both deleterious and protective92,103.  
Previous studies found that freshly purified NK cells are able to lyse human monocytes infected with 
BCG104, M. avium complex105 or M.tb106.  NK cells can mediate the early killing of intracellular M.tb97 
and can promote the killing of M.tb either directly or indirectly107.  When NK cells bind to the 
microorganism, direct cytotoxicity can occur via cytotoxic molecules, and indirect killing occurs 
through secreted cytokines108.  These cytokines activates macrophages and other members of the 
immune system which results in the killing of microorganisms108.  The hypothesis that human NK cells 
directly interacts and responds to mycobacteria was made as early as 1996109.  A direct interaction 
between NK cells and mycobacteria can promote the activation, proliferation, cytokine production and 
lytic activity in the absence of an antigen-specific T cell response during early infection. This 
mechanism can then help destroy intracellular bacteria by ensuring sufficient levels of macrophage-
activating cytokines or a cytotoxic activity against infected cells, when the majority of macrophages 
may be inadequately equipped to destroy intracellular bacteria109. 
 
It is therefore possible that NK cell proliferation are dependent on direct bacteria-cell contact109. 
Specifically, it was shown that the proliferation of NK cells after exposure to extracellular BCG was 
not caused by soluble factors released by the bacteria, but was due to a direct interaction between NK 
cells and mycobacteria110.  The same observation was made when NK cells were stimulated with heat 
killed BCG/ mycobacterial cell-wall preparations, but this was not observed when the cells and bacteria 
were separated by a 0.22µm pore membrane.  The membrane inhibited cell-bacteria contact, but not 
the passage of soluble factors.  Intact mycobacteria may thus be a sufficient stimulus to promote NK 
cell responses, even without accessory cell derived cytokines109,111,112.  This was seen in most studies, 
but not in all69,113.  In vitro studies support the role of NK cells in anti-mycobacterial immunity. 
Multiple mechanisms contribute to the restriction of intracellular M.tb growth by NK cells.  Induction 
mechanisms of NK cell functions depend on the type of antigen109.  T cell responses are modulated by 
NK cells which limits the availability of APCs114.  NK cells are activated by various cytokines, 
including IL-2, IL-18, IL-12 and IL-15, and through an imbalance between activating and inhibitory 
receptors72,115,116.  Direct recognition of PAMPs can also further activate these cells. 
 
Several clinical studies have investigated the potential association between NK cell counts and 
TB80,117,118.  Some studies reported a reduction in the frequency of NK cells in TB patients when 
compared to healthy controls118, whereas other studies show an increase in NK cell count in TB  
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patients119.  Migration of NK cells from peripheral blood to the site of infection has also been 
demonstrated30,120.  Furthermore the effector functions of NK cells obtained from TB patients have also 
been investigated and the majority of these studies reported impaired cytotoxic activity of  NK cells in 
TB patients121–123.   NK effector functions clearly play a role during TB infections with the two main 
effector responses being target cell killing (cytotoxicity) and cytokine production99. 
 
1.6.2.1 Cytotoxicity  
NK cells and CD8+ T cells are known as the most prominent cytolytic effector cells within the immune 
system124.  CD56dim  NK cells produce low levels of cytokines but are potent cytotoxic effector cells83.  
Target cells includes cells infected with viruses or intracellular bacterial pathogens, tumour cells and 
immature DCs125.  This response of NK cells is mediated by cytotoxic molecules which is stored in 
specialized exocytic organelles called secretory lysosomes108.  Secretory lysosomes are dual function 
organelles124,126 and target cell recognition induces exocytosis of cytotoxic contents108.  The major 
cytotoxic proteins contained within the NK cells are perforin, granzymes and granulysins127–129.  
Perforin belongs to the membrane-attack-complex protein family130.  This protein facilitates the entry 
of granzymes and granulysins into the target cell cytoplasm108,131, but the mechanism is still unclear127.  
Perforin can also complete additional cytolytic functions in the target cell after the transport of the 
cytotoxic molecules132.  Then lastly, granulysins are proteins that can interact with lipids and two 
isoforms of granylysin exist in NK cells133.  Granulysin can destroy extracellular M.tb on its own but 
requires the presence of perforin to kill intracellular M.tb133.   
 
The major constituent in NK cells is granzyme B which is part of the serine protease family134.  When 
an immune synapse is formed between the target cell and the NK cells, the cytotoxic granules move 
into a synaptic cleft and the granzymes are delivered into the target cell127.  Granzyme B causes target 
cell apoptosis and this occurs through direct activation of caspases 3 and 7134.  Apoptosis can also occur 
through proteolysis of the protein Bid as illustrated in figure 1.6.  This enzyme can have an effect in 
the absence of perforin, but the full effect will not be observed134.  NK cells rapidly respond to the 
activation of signals and can be directly cytolytic without the need of proliferation or transcription49.  
On average NK cells can kill four target cells each, but subsequently perforin and granzyme B levels 
decrease and the cell is worn out135.  IL-2 treatment of  NK cells restores their cytotoxicity, presumably 
due to increased expression of granzymes and perforin108.  The activity of NK cells must be regulated 
to prevent auto reactivity against the host136.  NK cell cytotoxicity is regulated by two receptor 
families137.  
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Figure 1.6: NK cell cytotoxicity. Granzyme B, granulysin and perforin are released from NK cell granules. 
Granzyme B enters the target cell cytoplasm with assistance from perforin and initiates apoptosis.  Adapted from 
Hiebert et al. 2012138. 
 
1.6.2.2 Cytokines  
Although the lytic ability of NK cells against a variety of cell targets is crucial, cytokine production by 
these immune cells is also of significant importance and has an immense influence on host-
immunity109.  Cytokines are required for protection against disease, but also contribute to the 
progression or development of pathophysiology139.  Cytokines have a short half-life and induce 
biological effects by binding to the extracellular moiety of specific transmembrane receptor proteins 
in the outer membrane of cells.  This binding induces a coordinated series of intracellular events leading 
to functional changes in these cells140.  Previous studies established that cytokines also play a major 
role in determining the outcome of M.tb infection141.  
 
Cytokines control initial infection and can promote or maintain the adaptive T cell responses that 
mediates host resistance142.  Therefore, cytokines plays a major role in the innate and adaptive immune 
response.  The CD56bright NK cells have the ability to produce high levels of immunoregulatory 
cytokines and can also produce chemokines like Macrophage inflammatory protein 1- alpha (MIP-1α) 
and Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES)115.   
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Cytokine regulation in human NK cells is understudied143.   Some of the cytokines produced by NK 
cells and their role in the immune system will be discussed here. 
 
Interferon-gamma (IFN-γ):   
Interferons are a group of proteins and glycoproteins that are produced in response to infections.  IFN-
γ has pleiotropic adjuvant effects on host defences and is one of the key cytokines in the control of 
M.tb infections.  It plays a critical role in the regulation of inflammatory responses and is important in 
host protection from a number of infectious agents144–147.  
 
It is known that IFN-γ gene defects in humans makes them prone to serious mycobacterial infections148.  
In certain infectious diseases, an inadequate IFN-γ response or inability to respond to IFN-γ is 
associated with persistent infection or even increased host mortality145,146,149.  The primary source of 
this cytokine was considered to be conventional CD4+ and CD8+ T cells, but it is now known that 
innate lymphocytes, NKT cells, NK cells and γδT cells produce IFN-γ in response to M.tb 
stimulation141.  The production of IFN-γ by T cells can be induced after recognition of specific antigens 
by the T cells whereas NK cell production of IFN-γ is not antigen specific and can be driven by DCs 
or macrophage derived IL-12150,151.  The IFN-γ produced stimulates macrophage activation which 
subsequently increase cytokine synthesis leading to increased NK cell IFN-γ production152.  Processed 
bacterial products can also increase the cytokine stimulation of IFN-γ production.  The release of both 
inhibitory and stimulatory cytokines balances the regulation of IFN-γ production by NK and Th1 
cells152.  Chace et al. showed that NK cells do not secrete IFN-γ after challenge with bacterial DNA, 
however in the presence of macrophages, IFN-γ is produced, and that the requirement for the presence 
of macrophages can be replaced with exogenous IL-12149.  
 
Interleukin-12 (IL-12): 
This  heterodimeric cytokine is mostly produced by phagocytic cells in response to bacterial products 
and intracellular parasites147.  IL-12 is produced during early infection and stimulates the production 
of  IFN-γ from NK and T cells60.  This pathway links the innate with the Th1 adaptive response to 
M.tb.  It also acts as growth factor for activated T and NK cells and enhances the cytotoxic activity of 
NK cells150.  IL-12 (in vivo) acts in three states during innate resistance and adaptive immune response 
to infection150.  In the first stage, IL-12 production induce NK and T cells to produce IFN-γ.  This 
contributes to phagocytic cell activation and inflammation.  IL-12 and IL-12 induced IFN-γ favour Th1 
cell differentiation by priming CD4+ T cells for high IFN-γ production during the second stage.   
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In the third stage, IL-12 contributes to optimal IFN-γ and contributes to the proliferation of 
differentiated Th1 cells in response to antigens150.   Hence IL-12 represents a functional bridge between 
early non-specific innate resistance and antigen-specific adaptive immunity.  IL-12 can be strongly 
inhibited by IL-10 and therefore contributions of IL-10 and IL-12 may determine whether IFN-γ based 
inflammation response is sufficient to combat the infection149.  
 
 
Figure 1.7: IL-12 gets produced by APC.  This is a potent inducer of NK IFN-γ. During a systemic infection: 
Increased IL-12 production leads to IFN-γ + IL-10 production by NK cells with an outcome that will be in favour 
of the immunosuppressive function of IL-10 on T cell and APC responses. Local infections: this leads to a low 
IL-12 production which then only triggers IFN-γ production by NK cells and results in a positive feedback loop 
between NK cells and APC.  Adapted from Vivier & Ugolini, 2009153. 
 
Interleukin-10 (IL-10): 
IL-10 is an anti-inflammatory cytokine.  Earlier studies have struggled to demonstrate IL-10 production 
by NK cells, but it was subsequently shown that NK cells produce IL-10, in smaller amounts compared 
to the amount produced by T cells or monocytes154–157.  This cytokine can directly regulate innate and 
adaptive Th1 and Th2 responses as well as supress pro-inflammatory responses in tissue157.   
It also directly inhibits T cell, macrophages and NK cell responses and APC functions of cells that are 
infected with mycobacteria158 (Figure 1.7).  The macrophage-deactivating properties of this cytokine 
lead to a decrease in the production of IFN-γ as previously discussed.  This cytokine is also a major 
regulator of IL-12 dependent immune response and directs the Th1 pathway (Figure 1.7).  When IL-
10 gets produced by NK cells it can lead to decreased inflammatory processes and increased NK cell 
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effector responses153.  This contributes to the evidence that NK cells exert regulatory functions153.  
Additionally, when isolated NK cells are stimulated with IL-2, they produce low levels of IL-10.  
 
Tumor necrosis factor (TNF):  
TNF is a potent inflammatory cytokine and modulates early inflammatory responses to a variety of 
environmental, infectious and immunological stimuli159.  This cytokine is also part of the group of 
cytokines that are involved in stimulating the acute phase response160 and plays multiple roles in the 
immune and pathologic responses to TB.  It is involved in the regulation of cell survival, affects cell 
migration within tissues in M.tb infections, has pro-inflammatory properties and regulates IFN-γ 
positively60,161,162. This cytokine also plays a major role in the formation and maintenance of 
granulomas162.  Individuals undergoing TNF modulation treatment for chronic inflammatory diseases 
provided the first evidence that TNF is necessary for preventing reactivation of TB112.  Anti-TNF 
therapy interferes with innate immune responses such as phagolysomal maturation as well as cell-
mediated responses which includes IFN-γ secretion by memory T cells and increased T cell 
activity112,163.  Mice deficient in TNF do not form proper granulomas in their lungs and these mice are 
unable to control M.tb infections164,165.  Clinical studies also found associations between TNF blockers 
and progression from LTBI to TB112,163.  TNF is known to support anti-TB immunity through secretion 
of chemokines166, induction of macrophage apoptosis167 and the upregulation of adhesion molecules168.  
It acts in synergy with IFN-γ to induce antimicrobial activity via induction of reactive oxygen and 
nitrogen intermediates160.   
 
Granulocyte macrophage colony stimulating factor (GM-CSF):  
This prominent haematopoietic cytokine immune regulator can be released by a multitude of cell 
types169.  GM-CSF can expand DC numbers, enhance their immunostimulatory capacity170 and in the 
context of TB, GM-CSF may also contribute to the chemokine/cytokine milieu responsible for 
granuloma formation in the lung171.  Careful regulation of pulmonary GM-CSF levels may be critical 
in sustaining protection against chronic TB disease since over expression of GM-CSF in lungs impairs 
protective immunity against M.tb172.  This is one of the cytokines that NK cells produce that are capable 
of enhancing blood phagocytic activity and increases its microbicidal capacity173.  GM-CSF is a heavily 
glycosylated cytokine and can recruit circulating monocytes and lymphocytes to enhance their 
functions in the host response.  This cytokine is an important mediator in lung inflammatory models, 
controls macrophage numbers and TLR-4 expression169.  A study done by Nambiar et al. found that 
the predominant effect of GM-CSF on T cell immune responses is exerted through the increase 
presence of IL-12 secreting DCs172.  
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Interleukin-17A (IL-17A):  
IL-17A is an inflammatory cytokine which  initiates inflammation174,175.  It can induce production of 
many neutrophilic granulocyte attracting chemokines (chemokine (c-x-c motif) ligand (CXCL)-1, 2, 5, 
8) and T cell attracting chemokines (chemokine (c-c motif) motif (CCL)-2,7,20) in epithelial and 
endothelial cells176,177.  Both polymorphic and mononuclear cells can be regulated by IL-17 during 
mycobacterial infection and IL-17 responses are largely dependent on IL-23178.  IL-17 is mainly 
produced by subsets of  T cells known as Th17 and Th22 but it is also produced by NK cells140,178.  
 
Interleukin-22 (IL-22):  
IL-22 is a novel type of immune mediator that increases innate immunity of tissue cells, enhances tissue 
regeneration and protects from tissue damage140.  The primary source of IL-22 are Th17 and or Th22 
cells, however NK cells can also produce IL-22 at mucosal sites179–181.  The production of this cytokine 
by NK cells can inhibit intracellular growth of M.tb through enhancing phagolysosomal fusion182.  The 
type of cells that actually contributes to IL-22/IL-17A production in vivo depends on the kind and 
extent of inflammation, the type of pathogen and the site of pathogen entry140.  The role of this cytokine 
against extracellular bacteria in the lung has been characterized in a mouse model of Klebsiella 
pneumonia induced pneumoniae180,183,184.  IL-22 contributes to optimal host defence and does not 
require T cells for its production.  In addition to this, NK cells is also able to produce IL-22 in the 
absence of T cells102.   
 
The IL-22 receptor is expressed on several epithelial tissues, including human bronchial epithelial 
cells102 and a beneficial role of IL-22 in host defence against extracellular bacteria includes maintaining 
barrier integrity and the up-regulation of bactericidal proteins179,180,185.  NK cells can also contribute to 
the production of IL-22 through indirect effects which is mediated by IL-6 and TNF-α NK cell products 
which can then induce IL-22 in T cells186,187.  The rs2227473 polymorphism,  in the IL-22 promoter 
was shown to be associated with TB susceptibility in the Chinese population188.  
 
The secretion of cytokines mediates important regulatory capabilities and is central to immunity and 
immunopathologies.  It is clear that the immune response to mycobacterial infections involves a 
plethora of cytokines which exhibit a multitude of cellular effects and this complex interplay has 
ultimately a big influence on the outcome of infection160.  The immediate response of NK cells must 
be tightly regulated since it can hold severe consequences in the event of inappropriate NK cell 
activation.  
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1.6.3 Receptors  
 
NK cells differ from T and B cells in that T and B cells possess a single antigen receptor that dominates 
activation and development; whereas NK cells rely on a vast combinative array of receptors189.  There 
are a multitude of activating and inhibitory receptors and the net balance of signals from these receptors 
makes it possible for the NK cells to effectively kill their targets, while maintaining self tolerance136.  
The initial hypothesis regarding NK cell activation is known as the ‘missing self’ or induced self-
hypothesis136,190.   This hypothesis postulates that the incomplete/absence of major histocompatibility 
complex (MHC) class I molecules in a normal cell would be sufficient to make it susceptible to NK 
cells without other changes being required191.  The loss of expression or down regulation of MHC class 
I molecules releases the inhibitory signal to NK cells and permits their activation136.  
 
The two main receptor systems of the NK cells includes members from the C-type lectin-like domain 
superfamily and immunoglobulin-like (Ig) superfamily136,190.  The receptors of these two families are 
preformed and non-rearranging and variability is a direct result of the genetically defined subset of 
genes present for each family.  This process differs from T and B cells which undergo rearrangement 
of gene clusters.  Complex combinatorial expression patterns forms with the development of NK cells.   
 
NK cells are not MHC restricted and eliminate target cells which have downregulated expression of 
MHC class I.  NK cells kills cells that are characterized by absent/down-regulated, modified MHC or 
human leucocyte antigen (HLA) class I molecules192.  These molecules are expressed ubiquitously on 
healthy cells and therefore provide NK cells with a means of identifying ‘self’136.  The two main 
receptor superfamilies have complementing MHC specificities: Ig superfamily (KIR molecules) are 
specific for HLA-A, -B, -C allotype subsets and HLA-G ligands193,194 and C-type lectin-like domain 
superfamily (CD94/NKG2 lectin like molecules) are specific for HLA-E and MHC class I polypeptide-
related sequence A (MICA).  
 
The expression of the receptors differs within the two subsets (CD56brightCD16dim and 
CD56dimCD16bright)  of NK cells and this allows for differential cytotoxic activities, trafficking 
properties and proliferative responses81.  The regulation of NK cell responses is not only due to a simple 
balance but can also be controlled by soluble factors including cytokines, chemokines and other 
secreted ligands of NK cell receptors195.  Both superfamilies include inhibitory and activating receptor 
variants.  Inhibitory and activating receptors are a complex group of receptors that uses opposing 
signalling motifs to stimulate or inhibit the cells effector responses196. 
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1.6.3.1 Activating receptors  
NK cells express more activating receptors than inhibitory receptors136.  The cells will mount an 
effector response when a critical threshold of activating signalling exceeds the counterbalance of the 
inhibitory receptors189.  Down-regulation of MHC class I or loss of its expression leads to activation of 
NK cells136.  Activating receptors contain the immunoreceptor tyrosine-based activation motifs 
(ITAM)189, however ITAM is not detected in the cytoplasmic tails of NKp46 and NKp44197.  ITAM-
bearing proteins all contains an aspartate residue within their transmembrane region.  This charged 
residue is needed for stable associations within the associated receptors189.  There are a number of 
different receptors that transduce activating signals through adaptor molecules and NK cells use several 
different activating pathways136. Dominant activating receptors on NK cells are NKG2D, DNAX 
accessory molecule (DNAM-1) and natural cytotoxicity receptors (NCRs).  
 
NCRs are a family of receptors which includes NKp46, NKp44, NKp30 and NKp80197.  The expression 
of NKp44 is confined to activated NK cells, whereas NKp30 and NKp46 is expressed on all NK 
cells199.  It is thought that this receptor initiates a pathway of NK cell triggering during the process of 
non-MHC restricted cytotoxicity by activated NK cells.  NKp30 co-operate with NKp46 and NKp44 
in the induction of cytotoxicity against a variety of target cells200.  NKp80 is expressed on all NK cells 
and mAB-mediated cross-linking of NKp80 resulted in induction of cytolytic activity.   
 
NKG2D is also expressed by NK cells as well as subsets of T cells198.  This is a homodimeric activating 
receptor and member of the C-type lectin family.  DNAM-1, CD2, CD16 and CD9 are surface 
molecules expressed by NK cells that have been shown to trigger NK cell mediated cytotoxicity in 
redirected killing assays197.  However none of these molecules appear to be directly involved in the 
triggering of natural cytotoxicity196.  Different receptor/ligand interactions may be responsible for the 
activation of NK cells upon interaction with target cells.   
 
1.6.3.2 Inhibitory receptors 
Inhibitory receptors that are specific for autologous MHC class I molecules are expressed by almost 
all mature NK cells201,202.  It was found that inhibition regulates NK cell function136.  Some inhibitory 
NK receptors are specific for MHC class I, whereas other inhibitory receptors binds non-MHC 
ligands189.   
 
Two receptor families that play the most prominent role in NK regulation by MHC class I are the KIR 
family and the lectin-like CD94/NKG2A receptor family136.  Both these receptors synergize to generate 
NK cells that are responsive to changes in MHC class I expression136.  Other inhibitory receptors 
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include leucocyte immunoglobulin-like receptors (LILRs) and the Ly49 receptors189.  The inhibitory 
receptors are diverse but share a common signalling motif in their cytoplasmic regions189.  
 
This motif is called the immunoreceptor tyrosine-based inhibitory motif (ITIM).  When ITIM-bearing 
receptors engage their ligands, a tyrosine residue is phosphorylated and this results in the recruitment 
of the lipid phosphatase SHIP-1. This degrades phosphatidylinositol-3,4,5-trisphosphate to 
phosphatidylinositol-3,4-bisphosphate203.  These phosphates are recruited to the interface between the 
NK cells and its target cells and this suppresses NK cell responses203.   
 
1.7 Killer immunoglobulin-like receptors (KIRs) 
Killer immunoglobulin-like receptors (KIRs) belong to the immunoglobulin superfamily and are type 
1 transmembrane glycoproteins.  The genes are highly polymorphic and are encoded on chromosome 
19q13.4 within the leucocyte receptor complex (LRC).  All of the KIR genes are encoded within a 
range of 160kb genomic sequence, and they cluster together with a genetic distance shorter than 3kb193.  
This receptor family has unique structures which enables them to recognize MHC class I molecules 
with locus and allele-specificity204.  There are extensive functional, genetic and expression diversity 
within the KIRs that can impact NK cells at several levels.  The KIR genes are diverse and vary at both 
allelic polymorphism and gene content194,205.  Moreover, KIRs are clonally expressed in a stochastic 
manner to generate a repertoire of NK cells expressing different combinations of KIRs in the same 
individual194,201.  Every person has an unique repertoire of NK cells due to their different set of inherited 
genes and alleles coding for a different NK cell receptor and secondly, due to stochastic expression of 
these genes among the cells from the same individual206.  This may affect cytokine production in 
response to M.tb which leads to innate viability and thus different levels of susceptibility to M.tb 
infection30.  This could be one of the reasons why there is such a vast difference between individuals 
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1.7.1 Nomenclature  
 
KIR gene nomenclature is defined by the WHO committee and is subcategorized by considering the 
number of extracellular domains and the length of their cytoplasmic tails.  The number of extracellular 
domains (Ig-domains) can either be two or three (2D or 3D)136.  There are thus two structural groups 
into which KIRs can be identified: KIR2D or KIR3D.  KIRs are also classified as activating or 
inhibitory.  Activating KIRs (aKIRs) (with ITAM) contain short cytoplasmic tails and are designated 
as 2DS and 3DS.  The long cytoplasmic tails are in general associated with the ITIM, and inhibitory 
KIRs (iKIRs) are classified as 2DL and 3DL136.  To date, 15 distinct KIR gene loci, including two 
pseudogenes, have been identified.  Each KIR gene encodes either an activating or inhibitory KIR with 
the exception of KIR2DL4, which shares structural features with both activating and inhibitory KIR136.  
The expression of KIR genes are highly complex.  
 
1.7.2 Haplotypes  
 
There are numerous haplotypes with different gene content segregation in human populations.  KIR 
genes are highly polymorphic and KIR haplotypes differ in terms of variation in the number and types  
of genes present among individuals207.  There are four genes (2DL4, 3DP1, 3DL2 and 3DL3) that are 
present in all haplotypes and they are known as framework genes208.  These framework genes have 
been found in all individuals tested to date, with very few exceptions209.  Highly homologous KIR 
genes are separated by short and equally homologous intergenic sequences.  
 
Haplotypes can be classified as A or B based on the number of aKIRs present210.  A haplotype contains 
only one aKIR gene (2DS4) whereas B haplotypes can contain one or more of the genes encoding 
aKIRs (2DS1, 2DS2, 2DS3, 2DS5, 3DS1)204,209.  Another difference between the two haplotypes is that 
haplotype B is variable; whereas haplotype A has a set number of KIR genes (9 genes) (Figure 1.8).  
Deletions and duplications of genes have led to many different haplotypes209.  KIRs that are expressed 
on NK cells becomes fixed through methylation of unexpressed KIR genes and patterns passed on to 
daughter cells during cell division211.  It appears that activating isoforms of the KIR family have 
evolved more rapidly than the iKIRs.  This can maybe be due to selection imposed by pathogens.  
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Figure 1.8:  The two haplotype groups of killer immunoglobulin-like receptors (KIR). (A) Indicates haplotype 
A and (B) indicates haplotype B.  Adapted from Middleton & Gonzelez, 2010209.  
 
1.7.3 KIRs and TB   
 
It is known that variations in the repertoire of KIR alleles expressed by NK cells between individuals 
are associated with known differences in susceptibility and resistance to diseases212.  Previous studies 
revealed that the expression of HLA/KIR haplotypes was a crucial determinant of NK cell 
responsiveness to tumour cell lines and pathogen-associated signals213,214.  Consequently, a number of 
studies have investigated the role of KIRs in TB susceptibility. 
 
Portevin et al. showed that KIR B haplotypes correlated with a higher responsiveness to extracellular 
mycobacteria and that this association was driven by KIR2DS3 and KIR2DS530.  This could suggest a 
possible link between KIR genotype and the ability of the respective NK cell repertoire to react to 
mycobacteria30.  Other studies have also addressed the influence of KIR genotypes on TB in different 
ethnic populations.  In a Lebanese population, the KIR A haplotype was found to be more prevalent in 
TB patients when compared to healthy controls215.  No associations were found in the Iranian 
population18.  A cross-sectional study compared KIR gene frequencies and haplotypes of individuals 
with active TB and latent TB, to TB and HIV negative controls.  KIR2DL2, KIR2DL5, KIR2DL5B, 
KIR2DS2 and KIR2DS3 differed significantly in this study conducted in Manitoba49.  Another study 
with participants from Xalapa, Veracruz and Mexico found that patients with KIR2DL3 differed 
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There is extensive variation between KIR genotypes in populations according to different geographical 
regions and different ethnic groups.  This can be due to the presence or absence of different KIRs in 
individual haplotypes and allelic polymorphism of KIR genes217,218.   A study that was conducted in 
the South African Coloured (SAC) population showed that the number and type of aKIRs were 
associated with TB disease.  In this study several KIR associations with TB were identified22.  The 15 
KIR genes were genotyped and the frequencies of all the genes were similar, except for KIR3DS122.  
This gene was found at a higher frequency in the controls when compared to the TB cases.  The 
presence of this gene lowered the odds (OR = 0.65, p = 0.014) of developing TB in the SAC population.  
This study also analysed the KIR genes by the number of activating or inhibitory genes present and it 
was observed that individuals with more than five aKIRs had a lower risk of developing TB (OR = 
0.67, p = 0.046).  One of the reasons that individuals with more aKIRs had a greater NK cell response 
to M.tb infections might be due to an increased IFN-γ response; whereas a lack of aKIRs might lead to 
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Scope of the thesis  
TB is a complex disease and only approximately 5-15% of infected, immunocompetent individual’s 
progress to active clinical disease.  M.tb infection is required for the development of TB, however it is 
not necessarily sufficient for causing active disease.  The precise host genetic factors that contributes 
to individuals being more susceptibility to TB remains a long-standing research challenge.  The 
identification of genetic factors that contribute to an individual’s ability to be protected against disease 
can translate into strategies to be used for therapeutic purposes and personalised medicine.  A previous 
study in our group determined that certain KIR genes may alter susceptibility to TB and an 
overexpression (≥ 5) of aKIRs offers protection against developing TB disease.  The research presented 
in this thesis aimed to compare the efficiency of mycobacterial killing by NK cells isolated from 
individuals with five or more aKIRs compared to individuals with less than five aKIRs.  We 
hypothesised that NK cells from healthy individuals with five or more aKIRs would be able to kill 
invading mycobacteria more efficiently than those with less than five aKIRs.  Individual’s KIR 
genotypes will be determined using a PCR-SSP genotyping protocol, after which PBMCs will be 
isolated from whole blood using density gradient centrifugation.  Pure NK cell populations will then 
be isolated from the PBMCs with the EasySep™ Human NK Cell Isolation Kit (Stemcell technologies, 
Canada).  The isolated NK cells will be stimulated with M.tb H37Rv and viability will be determined 




1) To identify five individuals with five or more aKIRs and five individuals with less than five 
aKIRs using PCR-based genotyping. 
2) To determine whether NK cells expressing five or more aKIRs are more efficient at killing 
mycobacteria compared to NK cells expressing less than five aKIRs. 
3) To determine the levels of cytokine production following mycobacterial stimulation in 
individuals with five or more aKIRs compared to those with less than five aKIRs.  
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Chapter 2: Materials and Methods  
 
2.1 Study participants and sample collection 
Study participants were recruited from the Department of Biomedical Sciences, Stellenbosch 
University, Cape Town, South Africa.  The participants were healthy without any symptoms of TB and 
were recruited based on verbal reporting of never having had active TB.  Given that the estimated 
frequency of five or more aKIRs in the South African population is 20%22, we recruited 30 control 
individuals for genotyping in order to identify individuals expressing five or more aKIRs and 
individuals with less than five aKIRs.  From each individual, 4mL of venous blood was collected by a 
trained phlebotomist in an EDTA tube (Kendon Medical supplies, South Africa) for DNA extraction 
(Figure 2.1).  Following genotyping of all 30 control individuals, a further 40mL of venous blood was 
drawn from 10 selected individuals in EDTA tubes for PBMC isolations over a three week period.  The 
10 selected individuals consisted of five with less than five aKIRs and the other five individuals had 
five or more aKIR genes.  In this thesis “group 1” will refer to individuals with less than five aKIRs 
and “group 2” will refer to individuals with five or more than five aKIRs.  All participants gave written 
informed consent to participate in the study.  The study was conducted in accordance with the best 
ethical practices as stated in the Declaration of Helsinki (2013) and was approved by the Health 
Research Ethics committee of Stellenbosch University, South Africa (project number S16/03/040).  
 
 Figure 2.1: Diagram indicating the sample collection process. 
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2.2 DNA extractions  
DNA was extracted with the Illustra Nucleon BACC3™ Genomic DNA extraction kit (GE healthcare, 
UK) following the instructions of the manufacturer.  This protocol can be briefly subdivided into five 
steps as indicated in figure 2.2.   The genomic DNA was extracted within 24 hours from venous blood 
collected in tubes containing EDTA anti-coagulant.  
 
 
Figure 2.2: Steps during the DNA extraction protocol. 
 
To initiate cell lysis, 4mL blood from each participant was transferred to a 50mL tube and filled with 
reagent A (Appendix I) to approximately 5x the blood volume and shaken for 2 minutes.  The tubes 
were covered with parafilm (Sigma-Aldrich, South-Africa) and centrifuged (Centrifuge 5810R, 
Eppendorf, Germany) at 3220 rcf, 4°C for 20 minutes.  The supernatant was decanted without losing 
the pellet and centrifuged (Centrifuge 5810R, Eppendorf, Germany) again at 3220 rcf, 4°C for 20 
minutes.  After the second centrifugation, the supernatant was decanted and the pellet was air dried. 
Two mL of reagent B and 5µL proteinase K was added to the pellet.  The pellet was dissolved at 37°C 
(37°C Incubator, Merret®, Germany) while shaking for ± 2 hours.  For deproteinisation, 500µL sodium 
perchlorate was added to the dissolved pellet in 15mL tubes and mixed (± 20 inversions).  DNA was 
extracted from the solution by adding 2mL chloroform and inverting until mixed.  Thereafter 300µL 
resin was very slowly added close to the surface so that it formed a middle layer as indicated in figure 
2.3, which was then centrifuged (Centrifuge 5810R, Eppendorf, Germany) at 800 rcf, 4°C for 8 
minutes.
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Figure 2.3: Extraction with chloroform treatment nucleon resin. Adapted from Illustra Nucleon BACC3™ 
Genomic DNA extraction kits product booklet. 
 
After the centrifugation step, the top layer was transferred into a 15mL tube without disturbing the 
resin.  Cold absolute ethanol was added (2x the volume of the pipetted top layer) and left overnight at 
4°C.  DNA was fished and added to a 2mL Eppendorf tube which was centrifuged (Eppendorf, 
Germany) at 14 000 rcf for 7 minutes.  The supernatant was decanted and the DNA was washed with 
70% ethanol and then centrifuged (Eppendorf, Germany) at 14 000 rcf for 7 minutes.  The ethanol was 
completely decanted after which the Eppendorf tube was placed upside down to air dry.  TE buffer 
(Appendix I) was added according to the size of the pellet and the DNA concentrations were determined 
using the Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific, South Africa) and the 
Nanodrop v3.7.1 Software.  Samples were diluted to a final working stock solution of 100ng/µL and 
stored at -20°C.  
 
2.3 KIR genotyping  
The absence or presence of KIR genes was determined using the gene-specific PCR-sequence specific 
primers (SSP) method219.  This method is based on the 3’-mismatched principle where primers are 
designed which will and will not allow amplification. 
 
2.3.1 Gene-Specific PCR-SSP protocol 
 
Each KIR gene has two sets of primers that aligned to two different regions of the gene (except for 
KIR2DS1).  The primer sequences that were used for this method are listed in table 2.2.
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The PCR Mastermix was prepared for each sample in a total volume of 215μL (Table 2.1).  One µL 
(100µg/µL) of both the forward and reverse primers per gene were added to an Eppendorf tube and 
4μL of the PCR cocktail was added to each tube for a total PCR volume of 6μL.  For the negative 
control 4µL of PCR cocktail was added and 2µL of the dH20 and DR beta 1 (DRB1) was used as the 
positive control.   
 
Table 2.1: Preparation of the PCR Mastermix. 
PCR Mastermix  Volume (µL) 
Kapa Taq readymix (Kapa Biosystems, Cape Town) 125 
Distilled water (dH20) 60 
DNA 30 
 
PCR reactions were done on the GeneAmp PCR system 9700 (Applied Biosystems, Germany) with 
the following cycling programme: 3 min at 94°C; 5 cycles of 15 s at 94°C ; 15 s at 65°C ; 30 s at 72°C 
; 21 cycles of 15 s at 94°C; 15 s at 60°C; 30 s at 72°C ; 4 cycles of 15 s at 94°C; 1 min at 55°C; 2 min 
at 72°C, with a final 7 min extension step at 72°C.  
 
PCR amplicons were loaded together with 5µL Cresol Loading Dye (Sigma-Aldrich, South Africa). 
Gels were stained with ethidium bromide (Sigma-Aldrich, South Africa), and 100bp Universal DNA 
ladder (Kapa Biosystems, South Africa) was loaded to confirm the size of the amplified products.  All 
PCR reactions were electrophoresed on a 1% agarose gel (Appendix I) (Sigma-Aldrich, South Africa) 
at 200V for 15 minutes.  The amplicons were visualized with UV light.  Gel visualization and image 
capturing was completed using the G-Box (Syngene, UK) and the Gene Snap program was used.  Both 
primers should be visible if the gene is present and if the gene is absent, no product should be visible.  
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Table 2.2: List of primer sequences used for KIR typing by the PCR-SSP method.  
Name  Sequence (5’ – 3’) Exon Size (bp) 
2DLIF1 GTTGGTCAGATGTCATGTTTGAA 4 146 
2DL1R1 GGTCCCTGCCAGGTCTTGCG 4 
2DL1F2 TGGACCAAGAGTCTGCAGGA 8 330 
2DL1R2 TGTTGTCTCCCTAGAAGACG 3’UTR 
    
2DL2F1 CTGGCCCACCCAGGTCG 4 173 
2DL2R1 GGACCGATGGAGAAGTTGGCT 4 
2DL2F2 GAGGGGGAGGCCCATGAAT 5 151 
2DL2R2 TCGAGTTTGACCACTCGTAT 5 
    
2DL3F1 CTTCATCGCTGGTGCTG 7 550 
2DL3R1 AGGCTCTTGGTCCATTACAA 8 
2DL3F2 TCCTTCATCGCTGGTGCTG 7 800 
2DL3R2 GGCAGGAGACAACTTTGGATCA 9 
    
2DL4F1 CAGGACAAGCCCTTCTGC 3 254 
2DL4R1 CTGGGTGCCGACCACT 3 
2DL4F2 ACCTTCGCTTACAGCCCG 5 288 
2DL4R2 CCTCACCTGTGACAGAAACAG 5 
    
2DL5F1 GCGCTGTGGTGCCTCG 3 214 
2DL5R1 GACCACTCAATGGGGGAGC 3 
2DL5F2 TGCAGCTCCAGGAGCTCA 5 191 
2DL5R2 GGGTCTGACCACTCATAGGGT 5 
    
2DS1F1 CTTCTCCATCAGTCGCATGAA 4  
102 2DS1F2 CTTCTCCATCAGTCGCATGAG 4 
2DS1R1 AGAGGGTCACTGGGAGCTGAC 4 
    
2DS2F1 TTCTGCACAGAGAGGGGAAGTA 4 175 
2DS2R1 GGGTCACTGGGAGCTGACAA 4 
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2DS2F2 CGGGCCCCACGGTTT 5 240  
2DS2R2 GGTCACTCGAGTTTGACCACTCA 5 
    
2DS3F1 TGGCCCACCCAGGTCG 4 242 
2DS3R1 TGAAAACTGATAGGGGGAGTGAGG 4 
2DS3F2 CTATGACATGTACCATCTATCCAC 5 190 
2DS3R2 AAGCAGTGGGTCACTTGAC 5 
    
2DS4F1 CTGGCCCTCCCAGGTCA 4 204 
2DS4R1 TCTGTAGGTTCCTGCAAGGACAG 4 
2DS4F2 GTTCAGGCAGGAGAGAAT 5 197/219 
2DS4R2 GTTTGACCACTCGTAGGGAGC 5 
    
2DS5F1 TGATGGGGTCTCCAAGGG 4 126 
2DS5R1 TCCAGAGGGTCACTGGGC 4 
2DS5F2 ACAGAGAGGGGACGTTTAACC 4 178 
2DS5R2 ATGTCCAGAGGGTCACTGGG 4 
    
3DL1F1 CGCTGTGGTGCCTCGA 3 191 
3DL1R1 GGTGTGAACCCCGACATG 3 
3DL1F2 CCCTGGTGAAATCAGGAGAGAG 4 186 
3DL1R2 TGTAGGTCCCTGCAAGGGCAA 4 
    
3DL2F1 CAAACCCTTCCTGTCTGCCC 3 211 
3DL2R1 GTGCCGACCACCCAGTGA 3 
3DL2F2 CCCATGAACGTAGGCTCCG 5 130 
3DL2R2 CACACGCAGGGCAGGG 5 
    
3DS1F1 AGCCTGCAGGGAACAGAAG 8 300 
3DS1R1 GCCTGACTGTGGTGCTCG 3’UTR 
3DS1F2 CCTGGTGAAATCAGGAGAGAG 4 180 
3DS1R2 GTCCCTGCAAGGGCAC 4 
     
Stellenbosch University  https://scholar.sun.ac.za
  Chapter 2: Materials and Methods 
Page | 31 
 
3DL3F1 GTCAGGACAAGCCCTTCCTC 3 232  
3DL3R1 GAGTGTGGGTGTGAACTGCA 3 
3DL3F2 TTCTGCACAGAGAGGGGATCA 4 165 
3DL3R2 GAGCCGACAACTCATAGGGTA 4 
    
2DP1F1 GTCTGCCTGGCCCAGCT 3 205 
2DP1R1 GTGTGAACCCCGACATCTGTAC 3 
2DP1F2 CCATCGGTCCCATGATGG 4 89 
2DP1R2 CACTGGGAGCTGACAACTGATG 4 
    
DRB1F1 TGCCAAGTGGAGCACCCAA Intron 3 796 
DRB1R1 GCATCTTGCTCTGTGCAGAT Intron 3 
*bp, base pair; UTR, untranslated region  
*numbering based on KIR alignment from http://www.ebi.ac.uk/ipd/kir/220 
 
2.4 Peripheral blood mononuclear cell (PBMC) isolation  
The PBMCs were isolated from peripheral blood within four hours of drawing, using density gradient 
centrifugation protocol (SUN immunology research group, Stellenbosch).  Briefly, 15mL density 
medium (ficoll-paque plus) (Sigma-Aldrich, South Africa) was added to 50mL tubes and the diluted 
blood (1:1 with 1x Phosphate buffer saline (PBS)) (Appendix I) was slowly pipetted over the ficoll-
paque layer (Figure 2.4).  The 50mL tubes were centrifuged (Centrifuge 5810R, Eppendorf, Germany) 
at 400 rcf for 25 minutes at room temperature, with no brakes and zero acceleration.  The plasma layer 
was removed (top layer as indicated in figure 2.4) and the PBMC interface was removed using a Pasteur 
pipette and washed with PBS by centrifugation (Centrifuge 5810R, Eppendorf, Germany) at 400 rcf, 
10 minutes at RT.  Thereafter the pellet was resuspended in residual PBS and washed again with PBS 
(centrifuge at 400 rcf, 10 minutes at RT).  The viability of the PBMCs were estimated by trypan blue 
dye (Thermo Fisher Scientific, South Africa) exclusion using a Countess™ II FL Automated cell 
counter (Thermo Fisher Scientific, South Africa).  The total number of viable cells were calculated as 
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Figure 2.4: Overview of the layers that form before and after the centrifuge step during the isolation of PBMCs. 
The PBMCs interphase can be subdivided into lymphocytes and monocytes. RBCs, red blood cells; PBS, 
phosphate buffer saline.  
 
2.5 Cryopreservation 
The cryomedia which consists of 10% Dimethyl sulfoxide (DMSO): heat inactivated fetal bovine 
serum (FBS) (Sigma-Aldrich, South-Africa) was prepared (Appendix I).  Two mL of cryomedia was 
prepared per cryovial.  The PBMCs were resuspended in residual PBS (Sigma-Aldrich, South Africa) 
by gentle flicking and the cryomedia was added to the cells drop by drop while on ice.  The cells were 
transferred to pre-cooled 2mL cryovials (Merck, South Africa) and frozen in a Nalgene Cryo freezing 
container (Sigma-Aldrich, South Africa) at -80°C overnight. This method lowers specimen temperature 
by approximately 1°C per hour.  The vials were removed within 24 hours and transferred to liquid 
nitrogen (LN).  
 
2.6 Thawing PBMCs  
Cryovials were removed from LN and transferred into a 37°C water bath (Imperial III water bath, 
Imperial Scientific works, India) for 10 minutes with an occasional gentle “flick” during thawing.  After 
adequate thawing the vials were removed from the water bath and immediately sterilized by spraying 
the outside with 70% ethanol.  
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2.6.1 Removing DMSO from PBMCs  
 
DMSO (Sigma-Aldrich, South Africa) is used as a cryoprotectant and added to cell media to reduce 
ice forming, thereby preventing cell death during the freezing process.  It is used in a slow-freeze 
method after which cells can be stored in LN.  In order to remove this toxic substance from the frozen 
stocks and to ensure viability of the cells, the following method was used: 1mL of pre-warmed (37°C) 
thawing media (Appendix I) was added to each cryovial in a drop wise manner and the cells were gently 
resuspended 3-5 times.  Each sample consisted of 30 cryovials and thus 6 x 50mL tubes were prepared 
per sample.  Five of the cryovials were transferred to each 50mL tube.  An additional 45mL of thawing 
media (Appendix I) was added very slowly.  All tubes were centrifuged (Centrifuge 5810R, Eppendorf, 
Germany) at 400 rcf for 10 minutes at RT.  After centrifugation the waste was decanted and the pellet 
was resuspended in residual media.  A final volume of 45mL thawing media was added to each 50mL 
tube and centrifuged (Centrifuge 5810R, Eppendorf, Germany) at 400 rcf for 10 minutes at RT.  
 
2.7 Cell counting  
A 1:10 dilution of cells: trypan blue was prepared.  Ten µL of cells (resuspended in cryomedia) were 
pipetted into a sterile Eppendorf tube and 80µL of sterile 1xPBS was added to the cells.  Thereafter 
10µL of trypan blue (Thermo Fisher Scientific, South Africa) was added to the diluted cells.  After 
thorough mixing, 10µL of the sample mixture was added into the filling notch in the counting chamber 
of the prepared Neubauer haemocytometer (Celeromics technologies, Spain).  The chamber was then 
placed on the platform of a microscope (Nikon TMS, Nikon instruments Inc., USA) and the cells were 
visualised under the lowest magnification.  
 
The Countess™ II FL Automated cell counter (Thermo Fisher scientific, South Africa) was used as an 
additional method to count the cells.  For each cell count using the Countess™ II FL Automated cell 
counter (Thermo Fisher scientific, South Africa), 10µL cells, 10µL trypan blue and 80µL sterile 1xPBS 
were mixed together.  Ten µL of this mixture was gently pipetted into the half-moon shaped sample 
loading area of the loading Countess chamber ™ slide (Thermo Fisher scientific, South Africa). The 
sample is loaded by capillary action. The entire counting area was covered with the cell suspension (no 
bubbles must be present) to ensure accurate results of the cell viability.  The sample mixture was left 
to settle for 30 seconds and then the slide was inserted into the slide port.  The total number of cells 
was calculated as indicated in appendix II.  
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2.8 NK cell isolation  
The EasySep™ Human NK Cell Isolation Kit (Stemcell technologies, Canada) was used for the NK 
cell isolations.  This kit uses antibody recognizing specific cell surface markers to target non-NK cells. 
The unwanted cells are labelled with antibodies and magnetic particles, and separated with the use of 
a magnet.  The desired cells (NK cells) are then poured into a new 15mL tube.  This is a form of 
negative selection.  For the NK cell isolation, PBMCs were thawed and the pellet was resuspended in 
900µL thawing media and 100µL DNase I solution (Thermo Fisher Scientific, South Africa) followed 
by 20 minutes incubation at 4°C.  Thereafter, the NK cells were isolated according to the protocol as 
suggested by the manufacturer (Stemcell technologies, Canada) with a few minor adaptations.  The 
incubation times were increased from 5 minutes to 10 minutes and isolations were done at 4°C. 
Furthermore, after adding the isolation cocktail to the sample it was placed on a spinning wheel 
(Eppendorf, Germany).  An overview of the adapted protocol is given in figure 2.5.  
 
 
Figure 2.5: Overview of the adapted EasySep™ Human NK cell isolation protocol (Stemcell Technologies, 
Canada). This is a negative selection technique and the kit targets non-NK cells for removal with antibodies 
recognizing specific surface markers. The unwanted cells are labelled with antibodies & magnetic particles.   
Stellenbosch University  https://scholar.sun.ac.za
  Chapter 2: Materials and Methods 
Page | 35  
 
After pipetting the enriched cell suspension into a new 15mL tube, it is centrifuged at 400 rcf for 10 
minutes, RT.  The supernatant is poured off and the pellet is resuspended in 1mL RPMI-1640 (LONZA 
Group, Switzerland) and 2% FBS (Sigma Aldrich, South Africa).  Thereafter the cell count and the 
viability of the cells was determined by using a Countess™ II FL Automated cell counter (Thermo 
Fisher scientific, South Africa).  Cell counting calculations that were used can be seen in appendix II.  
 
2.9 Fluorescent activating cell sorting (FACS) analysis  
Flow cytometry is a method that characterizes single cells using different parameters such as size, 
granularity, extracellular surface and intracellular surface.  Fluorescent activating cell sorting (FACS) 
analysis is a specialized type of flow cytometry which can be used to sort a heterogeneous mixture of 
biological cells into sub-populations based on fluorescent labelling.  Cells stained using fluorophore-
conjugated antibodies can be separated from one another depending on which fluorophore they have 
been stained with.  To assess the purity of the isolated NK cell populations using the EasySep™ Human 
NK cell isolation kit (Stemcell technologies, Canada), FACS analysis was used.  A fraction of the 
thawed PBMCs from each sample was used as a control as well as the EasySep™ D magnetic particles 
(Stemcell technology, Canada) that were used for isolating the NK cells.  The cells were acquired on a 
FACSCANTO II instrument (BD Biosciences, USA) and analysed with the Flowjo V10 program 
(https://www.flowjo.com).  
 
2.9.1 Antibodies and fluorescent reagents 
 
Fluorophore-conjugated monoclonal antibodies (Biolegend, USA) used for flow cytometry are listed 
in table 2.3.  The emission and absorption spectrum of each fluorophore is indicated in appendix III.  
 
Table 2.3: The fluorophore-conjugated monoclonal antibodies.  
 
 
Fluorophore Antibody Dilutions Volume added [µL] 
APC_Cy7 CD3 1:160 0.25 
PerCP_Cy5.5 CD4 1:80 1.25 
PE_Cy7 CD8 1:40 2.50 
APC CD56 1:80 1.25 
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2.9.2 Antibody titration  
 
The first step in a multicolour flow panel is to do antibody titrations to determine the most efficient 
quantity of each antibody for optimal staining, with minimal wastage of unbound antibody221.  In this 
process a known amount of cells were stained with decreasing concentrations of antibodies.  
 
Previously isolated PBMCs were used for this optimization step.  Cells were added to 50mL tubes and 
22mL FACS buffer was added.  For each antibody, a dilution series was made (Figure 2.6).  One mL 
of cells in buffer was added to each FACS tube (round-bottom polystyrene tubes) (The Scientific group, 
South Africa).  FACS tubes were centrifuged (Centrifuge 5810R, Eppendorf, Germany) at 250 rcf for 
10 minutes.  The supernatant was decanted and the FACS tubes were tapped on a paper towel to dry.  
One hundred µL of prepared antibodies were pipetted into each FACS tube and 100µL staining buffer 
was added to an unstained FACS tube.  FACS tubes were vortexed (Vortex whirl mixer, Stuart® 
equipment, UK) and incubated in the dark at 4°C for 30 minutes.  Thereafter 1mL staining buffer was 
added to each tube and the FACS tubes were centrifuged (Centrifuge 5810R, Eppendorf, Germany) at 
250 rcf for 10 minutes.  Two percent formaldehyde (Appendix I) (Sigma-Aldrich, South Africa) was 
used to fix the cells and 100µL was added to each tube.  This was resuspended and vortexed (Vortex 
whirl mixer, Stuart® equipment, UK).  Thereafter 1mL of staining buffer was added and centrifuged 
at 400 rcf for 5 minutes.  The FACS tubes were left in 200µL staining buffer at 4°C in the dark until 
analysed.  The results were analysed using FlowJo V10 program (https://www.flowjo.com) to 
determine the best signal-to-noise ratio (Appendix III).  Data were analysed by determining the mean 
of positive (signal) and negative (noise) populations for each antibody. 
 
 
Figure 2.6: Antibody titration dilution series. The staining buffer consisted of 2% FBS and PBS. Each 
Eppendorf tube was vortexed before addition to the next Eppendorf tube.  
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2.9.3 Instrument quality control  
 
Various steps were taken to ensure that the instrument operates optimally on a daily basis.  These 
checks were performed through the Cytometer Setup & Tracing application (CS&T).  After an 
appropriate instrument warm-up period, the photomultiplier tubes (PMT) and amplifier gains were set 
to a standard configuration.  Thereafter a standard particle was analysed and monitored for mean of 
fluorescence level and coefficient of variation.   
 
2.9.4 Compensation  
 
The goal of colour compensation is to correctly quantify each dye with which a cell is labelled.  This 
is done by subtracting a portion of one detector’s signal from another, leaving only the desired signal.  
Five FACS tubes (The Scientific group, South Africa) were prepared as indicated in table 2.4.  All the 
compensation beads were anti-mouse (BD Biosciences, USA) except for CD4, which was anti-rat (BD 
Biosciences, USA) since its isotype is rat IgG2b.  The negative control tube was analysed on the BD 
FASCANTO II (BD Bioscience, USA) followed by the tubes containing the various compensation 
beads.  A cut off value of 100 000 events was chosen.  Data analysis was performed using FlowJo V10 
program (https://www.flowjo.com). 
 








Tube 3  
Comp- CD4 
Tube 4  
Comp-CD8 
Tube 5  
Comp-
CD56 






CD8 PE-CY7 [µL]    2.5  
CD56 APC [µL]     1.25 
Comp beads 
negative (drop) 
1 1 1 1 1 
Comp beads positive 
(drop) 
1 1 1 1 1 
FACS Buffer [µL] 100 100 100 100 100 
 
Stellenbosch University  https://scholar.sun.ac.za
  Chapter 2: Materials and Methods 
Page | 38  
 
2.9.5 Fluorescent minus one (FMO) 
 
FMO control is used to ensure that the spread of fluorophores into the channel of interest is correctly 
identified.  The control contained all the fluorophores in the panel, except the fluorophore being tested 
(Table 2.5).  Cells were resuspended in 1mL washing buffer (Appendix I) and added to each FACS 
tube (round-bottom polystyrene tubes) (The Scientific group, South Africa).  FACS tubes were 
centrifuged (Eppendorf, Germany) at 400 rcf for 5 minutes and 100µL of washing buffer was added to 
each tube.  Thereafter antibodies (BioLegend, USA) were vortexed and added as indicated in table 2.5.  
Cells were washed twice and resuspended in 200µL washing buffer.  The FACS tubes were left in the 
dark at 4°C until they were analysed.  
 




Unstained   
 





Tube 4  
FMO-
CD4 
Tube 5  
FMO-
CD8 




CD3 APC-Cy7 [µL]  6.25  6.25 6.25 6.25 
CD4 PerCP-Cy5.5 
[µL] 
 1.25 1.25  1.25 1.25 
CD8 PE-CY7 [µL]  2.5 2.5 2.5  2.5 
CD56 APC [µL]  1.25 1.25 1.25 1.25  
FACS Buffer [µL] 100 88.75 95.0 90.0 91.25 90.0 
Total Volume [µL] 100 100 100 100 100 100 
*Blue blocks indicate that the antibody was not added. FMO, fluorescent minus one. 
 
2.9.6 Sample preparation for FACS  
 
Cells were resuspended in 1mL FACS buffer (Appendix I), centrifuged (RT, 5 minutes at 400 rcf) 
(Eppendorf, Germany) and the supernatant was discarded.  Antibodies were added to each tube (Table 
2.3).  The FACS tubes were vortexed (vortex whirl mixer, Stuart® equipment, UK) and incubated at 
RT in the dark for 30 minutes. After the 30 minute incubation, 1mL FACS buffer was added, 
centrifuged (400 rcf, 5 minutes, RT) and the supernatant was discarded.  This step was repeated twice.  
Five hundred µL FACS buffer was added to each FACS tube and stored in the dark at 4°C until samples 
were analysed using the BD FACSCANTO II (BD Biosciences, USA) with a cut off value of 50 000 
events.  Sample preparation steps are indicated in figure 2.7. 
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Figure 2.7: Sample preparation for FACS.  A fraction of the PBMCs were stored before isolating the NK cells. 
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2.10 Bacterial strains and culture conditions  
M.tb H37Rv was grown in a biosafety level-3 (BSL3) facility in T25 flasks (Thermo Fischer scientific, 
South Africa) in Middelbrook 7H9 medium (BD Biosciences, USA) supplemented with 10% oleic 
acid-albumin-dextrose-catalase (OADC) (BD Bioscience, South Africa) and 0.2% (v/v) glycerol  
(Sigma-Aldrich, South Africa) (Appendix I).  One mL of M.tb H37Rv stock was thawed and added to 
5mL of the Middlebrook 7H9 medium. The flask was placed in the Merret® incubator (Merret, 
Germany) at 37°C for ± 5 days.  The optical density (OD) at 600nm was taken every 2nd day until an 
OD600 of 1 was reached (OD of 1 ~ 1 x 10
8 CFU/mL)222.  Thereafter the culture was kept at RT to 
prevent further growth of the bacteria.  The culture medium did not contain Tween 80 because this 
detergent possibly alters the mycobacterial cell wall and solubilizes various proteins and lipids223 .  
 
2.11 Ziehl-Neelsen stain 
This bacteriological stain is used to identify acid-fast organisms, mainly mycobacteria.  Initially, 
Carbol fuchsin stains every cell.  After destaining with acid-alcohol, only non-acid-fast bacteria are 
destained since they do not have a thick, waxy lipid layer like acid-fast bacteria.  When counter stain 
is applied, non-acid-fast bacteria captures the stain and become blue when viewed under the 
microscope. Acid-fast bacteria retain Carbol Fuchsin so they appear red. M.tb H37Rv was cultured 
until an OD600 of 0.8 was reached and then the stocks were frozen at -80°C.  ZN stain was completed 
for the M.tb H37Rv stocks to confirm that no contamination was present.  
 
Five µL fixative (10% formalin) (Merck, South Africa) was added to a microscope slide.  Thereafter 
20µL M.tb H37Rv culture was added, smeared onto the slide and heat fixed for 2 hours at 95 °C (Dry 
block heater, Thermo Fischer Scientific, South Africa).  The slide was flooded with Carbol Fuchsin 
and heated with a flame until steaming point, left for 5 minutes and rinsed with clean water.  The slide 
was flooded with acid-alcohol, left for 2 minutes, rinsed with clean water and flooded with Methylene 
Blue for 2 minutes.  After rinsing with water the slide was air dried for 20 minutes and examined using 
a four objective light microscope at 60X (oil immersion) magnification (LW Scientific, South Africa).  
2.12 Stimulations of NK cells with mycobacteria  
After NK cell isolations, the NK cells were seeded in 96 well plates (Merck, South Africa) (amount of 
cells per well depended on the total amount of cells isolated).  The layout for the plate is shown in 
figure 2.8 (Each block represents a well).  
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NK cells were either stimulated with 50U recombinant interleukin 2, human (hIL-2) (Sigma-Aldrich, 
South Africa) or seeded without hIL-2.  Each sample was completed on a separate 96 well plate.  All 
samples were analysed in triplicate.  M.tb H37Rv was passaged 15 times through a 1 mL/cc insulin 
syringe (Avacare®, South Africa) without creating any bubbles.  The bacteria was filtered through 
5µm filters (Merck, South Africa) and passaged with a 1mL/cc insulin syringe (Avacare®, South 
Africa) before adding the M.tb H37Rv to each well containing the NK cells.  The amount of M.tb 
H37Rv that was added to each well depended on the amount of NK cells seeded per well.  A multiplicity 
of infection (MOI) of five was used.  This indicates the ratio of agents to infection targets.  Thus there 
were five times more bacteria than cells in each well.  Calculations used to calculate the amount of 
cells and the amount of bacteria that must be added per well is indicated in appendix II.  
 
For the 1 hour stimulation the NK cells were incubated in the Shell lab incubator (Sheldon 
manufacturing, USA) at 37°C in air containing 5% CO2 for 1 hour and the 24 hour stimulation was left 
in the incubator for 24 hours before the supernatants was plated for CFUs.  M.tb H37Rv in RPMI-1640 

















































































   
 Figure 2.8: The 96 well-plate layout used when stimulating the isolated NK cells with M.tb H37Rv. 
Stimulations were done for a 1 hour and 24 hour period.  
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2.13 Colony forming units (CFUs) 
After the NK cells were stimulated with M.tb H37Rv, the supernatant was used to make a dilution series 
ranging from 10-1 to 10-7 as indicated in figure 2.9.  Serial dilutions of the supernatants were plated on 
Middelbrook 7H11 agar plates supplemented with 10% OADC (BD Bioscience, USA) and 5mL 
glycerol (Sigma-Aldrich, South Africa) (Appendix I). The Middlebrook 7H11 agar plates were 
incubated at 37°C for ±3 weeks inverted in the Merret® incubator (Merret, Germany).  Following this, 
the single bacterial colonies on each plate were counted.   
 
 
Figure 2.9: The dilution series that was used to determine the colony forming units (CFUs) of M.tb H37Rv after 
stimulation.  
 
2.14 Cytokine expression  
2.14.1 Human CD8 + T- cell Magnetic bead panel (Milliplex® map Kit, 
EMD)  
 
Milliplex® map is based on the Luminex xMAP® technology and in the present study, a 17-plex panel 
was used (EMD millipore’s Milliplex® map Human CD8 + T-cell magnetic bead panel).  This panel 
was used for the simultaneous quantification of the following in the culture supernatant samples: 
Perforin and Granzyme B.   
 
2.14.1.1. Preparation of tissue culture supernatant and reagents for immunoassay 
Two hundred µL of each sample was stored in polypropylene cryovials (Merck, South Africa) at -20°C 
in the BSL3 facility after each stimulation.  Before running the assay all the samples were filtered using 
0.2µm Millex® syringe filters (EMD Millipore, USA).  The samples were thawed at RT and then 
vortexed (Vortex whirl mixer, Stuart® equipment, UK) for 5 seconds.  Thereafter the samples were 
centrifuged (Eppendorf, Germany) for 2 minutes at 2000 rpm.  
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2.14.1.2 Preparation of reagents for immunoassay  
Antibody-immobilized beads  
Each antibody-bead vial was sonicated (Bransonic Ultrasonic bath sonicator) (Sigma-Aldrich, South 
Africa) for 30 seconds and then vortexed (Stuart® equipment, UK) for 1 minute.  Thereafter 80µL of 
each antibody-bead vial was added to a mixing bottle and bead diluent was added to make up the final 
volume to 5.6mL (since two plates will be run).  The mixed beads were vortexed (Stuart® equipment, 
UK) well before use.   
 
Quality controls (QC) 
Quality control 1 and 2 was reconstituted with 250µL deionized water.  The vial was inverted several 
times and vortexed (Stuart® equipment, UK).  The vials were left for 5-10 minutes before use.  
 
Wash buffer  
The 10x wash buffer was brought to RT and mixed to bring all the salts into solution and then 60mL 
of the wash buffer was diluted with 540mL deionized water.  
 
Preparation of standards  
Six polypropylene tubes were labelled, Standard 1 to Standard 6.  One hundred and fifty µL of Assay 
buffer was added to all of the tubes. Serial dilutions were then prepared by adding 50µL of the 
reconstituted Standard 7 to Standard 6 (mix well) and then 50µL of Standard 6 to Standard 5 etc. as 
indicated in figure 2.10.  
 
Table 2.6: Preparation of CD8 + T cell standard (standard 7) and working standards. 
Standard tube Volume of Deionized Water 
to add 
Volume of Standard to add  
Standard 7  250µL 0 
Standard tube  Volume of Assay Buffer to 
add 
Volume of Standard to add 
Standard 6  150µL 50µL of Standard 7 
Standard 5  150µL 50µL of Standard 6  
Standard 4  150µL 50µL of Standard 5  
Standard 3 150µL 50µL of Standard 4  
Standard 2 150µL 50µL of Standard 3 
Standard 1  150µL 50µL of Standard 2  
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Figure 2.10: The workflow for the preparation of the working standards.   Adapted from booklet Human 
CD8+ T-cell magnetic Bead panel kit booklet (EMD Millipore, USA).   
 
2.14.1.3 Assay procedure for Human CD8 + T- Cell Magnetic Bead panel  
All reagents were allowed to reach RT (20-25°C) before use.  The assay was performed as indicated in 
figure 2.11.  After the 16-18 hour incubation step, the plates were washed twice using Bio-plex Pro™ 
wash station (Bio-rad, USA). 
 
                        
Figure 2.11: Assay procedure of the Human CD8 + T-cell magnetic Bead panel (EMD Millipore, USA).  
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The plates were analysed on the Luminex® Bioplex 200 system (Bio-rad, USA) with the program, 
Bioplex manager.  Calibration and verification was done as part of the daily setup.  The plate layout is 




Figure 2.12: The 96 well -plate layout of plate 1 (A) and plate 2 (B) for Human CD8 + T cell magnetic bead 
assay. Standard 0 = blank, standard 1 = low concentration standard, standard 6 = Highest concentration std, QC1 
= Assay Quality control 1, QC2 = Assay Quality Control 2.  Evaluate QC1 and QC2 as recommended by kit 
manufacturer and the interpolate control just like any other sample.  Each circle represents a well. Each sample 
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2.14.2 Human Cytokine/Chemokine magnetic bead panel (Milliplex® map 
kit, EMD) 
 
This panel was used for the simultaneous quantification of the following cytokines in the culture 
supernatant samples: GM-CSF, IFN-γ, IL-10, IL-17A, RANTES and TNF-α.  The same steps were 
followed for the preparation of the samples and reagents. The standards that were used are indicated in 
table 2.7.  
2.14.2.1 Preparation of reagents for immunoassay  
Preparation of Antibody-immobilized Beads 
Individual bead vials were used.  Each antibody-bead vial was sonicated (Bransonic Ultrasonic bath 
sonicator) (Sigma-Aldrich, South Africa) for 30 seconds and then vortexed (Stuart® equipment, UK) 
for 1 minute.  Eighty µL of each antibody-bead vial was added to the mixing bottle and then to bring 
to a final volume of 5.6mL, bead diluent was added.  All the other reagents were prepared as described 
above.  
 
Table 2.7: Preparation of Human cytokine standard and working standards 
Standard concentration 
(pg/mL) 
Volume of Deionized Water 
to add 
Volume of Standard to add  
10,000 250µL 0 
Standard concentration  
(pg/mL) 
Volume of Assay Buffer to 
add 
Volume of Standard to add 
2000 200µL 50µL of 10 000pg/mL 
400 200µL 50µL of 2000pg/mL 
80 200µL 50µL of 400pg/mL 
16 200µL 50µL of 80pg/mL 
3.2 200µL 50µL of 16pg/mL 
   
The assay procedure that was used for Human Cytokine/Chemokine magnetic bead kit (EMD 
Millipore, USA) were also used for this kit.  The overview of the assay is given in figure 2.12.  These 
plates were run on Luminex MAGPIX® (Luminex Xmap technology, Bio-rad, USA) with the program, 
Bioplex manager.  Calibration and verification was done using the Calibration and performance 
verification kit (MAGpix, Bio-rad, USA). 
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Figure 2.13: The 96-well plate layout of plate 1 (A) and plate 2 (B) for the Human Cytokine/Chemokine 
magnetic bead assay. Standard 0 = blank, standard 3.2 = low concentration standard, standard 10 000= Highest 
concentration std, QC1 = Assay Quality control 1, QC2 = Assay Quality Control 2.  Evaluate QC1 and QC2 as 
recommended by kit manufacturer and the interpolate control just like any other sample.  Each circle represents 
a well.  The samples was done in triplicates for each time point as well as for stimulations with and without hIL-
2.  
2.15 Statistical analysis  
2.15.1 CFU counts analysis  
 
For the CFU counts analysis the R stats package v.3.2.4, (https://cran.r-project.org/bin/windows/base/) 
and nmle package v3.1-131 (https://cran.r-project.org/package=nlme) was used to perform the 
statistical analysis.  A p-value of 0.05 or less was seen as statistically significant. 
A 
B 
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Quantile-Quantile (Q-Q) plot 
A quantile-quantile (Q-Q) plot is a plot of the quantiles of the first data set against the quantiles of the 
second data set.  Therefore a Q-Q plot was used to determine if the CFU counts were normally 




Figure 2.14: Quantile-Quantile plot. Data are normal.  
 
Mixed effect model  
A mixed effect model was used to determine if there was a significant association between CFU counts 
and the amount of KIRs present, while correcting for NK cell purity, NK cell subsets and time.  A 
mixed effect model contains both random and fixed effects.  In this model the KIR genotype was set as 
the categorical factor (the two groups) and the NK cell purity, NK cell subsets (CD56dim /CD56bright) 
and time was set as fixed effects.  The random effect is the variance between samples in order to 
account for natural variation between individuals.  A few models were tested with Analysis of variance 
(ANOVA) to determine the model with the best fit (based on the model with the lowest odds ratio), 
which was the random effects mixed model.  In this model the CFU counts were modelled as a function 
of KIR genotype and time, while taking into account the interaction between the KIR genotype, NK 
cell purity and NK cell subsets.  
 
Fixed effect only model  
A fixed effect model is a statistical model where the model parameters are fixed (non-random 
quantities).  This model was used to determine whether the random effect (Variation between samples) 
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2.15.2 Luminex multiplex immunoassay data analysis  
 
The cytokines, perforin, IL-17A, IFN-γ and granzyme B, and the chemokine, RANTES were analysed. 
IL-10, GM-CSF and TNF-α was left out of the analysis because of missing data (OOR˂).  The program 
Statistica 64 (http://statistica.io/) was used to perform the statistical analysis.  
 
Normal probability plot 
A normal probability plot is a graphical technique used to assess whether data are normally distributed. 
Raw data are plotted against a theoretical normal distribution so that the points form a straight line and 
any deviation from this line indicates departures from normality.  A normal probability plot for all 5 
(Perforin, IL-17A, IFN-γ, granzyme B and RANTES) cytokines was computed (Appendix V).  The 
residuals (difference between the observed value and the estimated value of the quantity of interest) 
were plotted against the expected normal value.  
 
Mixed effect model  
For the mixed effect model, the fixed effects was set as the KIR group, stimulation and time.  
 
 
Three way repeated measures ANOVA (Analysis of variance)  
A three way ANOVA determines how a response or outcomes is affected by three factors.  This is used 
to determine if there is an interaction between three independent variables, namely the KIR genotype 
(the two groups), stimulation, time and a continues dependent variable (samples).  A p-value of 0.05 
or less was seen as statistically significant. 
 
Fisher’s least significant difference (LSD) test  
Following the three way ANOVA analysis, a Fisher’s LSD test was done.  This test can be performed 
after an analysis of variance, were the F-ratio lead to rejection of the null hypothesis (H0) to determine 
which means lead to the rejection of the null hypothesis.  The test compares the means of the KIR 
genotype, stimulation and time.  The result of IFN-γ were transformed using the logarithm base-10 to 
reduce variance in the distribution. 
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Chapter 3: Results  
 
3.1 Demographics of study participants  
All participants (n = 30) were recruited from the Division of Molecular Biology and Human Genetics 
(Stellenbosch University, South Africa).  None of these subjects had a history of active TB or had 
clinical signs or symptoms of active TB at the time of the study.  All the participants were over the age 
of 21. The self-identified ethnicity of both groups were 80% Caucasian and 20% South African 
Coloured.   Table 3.1 shows the age and sex proportions of the groups.  
                                            
Table 3.1: Sample characteristics of individuals.  
Samples Total number Age (Mean ± SD) No. of Males (Prop) 
KIR genotyping samples  30 28.08 ± 4.08 7 (0.23) 
Selected cohort  
Group 1 5 29.8  ± 7.79 1 (0.20) 
Group 2 5 30 ± 4.30 3 (0.6) 
*SD, Standard deviation  
*Prop, Proportion  
 
3.2 KIR genotyping  
Thirty individuals were genotyped for the six aKIRs to identify individuals with five or more aKIRs. 
The six aKIRs are KIR2DS1, 2DS2, 2DS3, 2DS4, 2DS5, and 3DS122,224.  KIR2DL4 is a framework 
gene and can be either activating or inhibitory in function.  However this gene was included as an aKIR 
in our study, since it carries only a single ITIM and displays very weak inhibitory potential225.   Figure 
3.1 is a representation of the genotyping results from one individual.  The KIR genotyping results of 
all 30 individuals are indicated in appendix VII as well as the frequencies observed for each gene.  The 
most predominant haplotype observed within this study was the B haplotype with a frequency of 80% 
within the starting cohort (n = 24) (Appendix VII).  However within group 1, the A haplotype was 
predominant (60%).  This was classified on the basis that haplotype B has one or more of the following 
genes, 2DS1-2DS5 and 3DS1 whereas these genes were absent in haplotype A.  If only one aKIR gene, 
2DS4, was present, it is classified as haplotype A220,226. 
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Figure 3.1: Agarose gel image of KIR genotyping.  The following KIRs were identified as present due to 
successful amplification: KIR2DL4, KIR2DS2, KIR2DS3, KIR2DS4 and KIR3DS1.  KIR2DS5 and KIR2DS1 
were not present (no amplification).  DRB1 was used as positive control. NC, Negative control. 
 
Ten individuals were selected for functional analysis, depending on their KIR genotype (Table 3.2). 
Five individuals with less than five aKIRs (group 1) and five with five or more aKIRs (group 2) were 
selected.  The genotyping success rate for the KIR2DL4 gene was 87% and 80% for KIR2DS4 
(Appendix VII).  However; KIR2DS4 was only observed at a frequency of 50% within the 10 selected 
individuals.  
 
Table 3.2: The KIR genotypes of the 10 participants. Samples 1-5 had less than 5 aKIRs and samples 6-10 had 
5 or more aKIRs.  KIR2DL4 is known to be a framework gene and as expected, this gene was observed in all 
the samples.  The amount of total aKIRs is indicated in the last column.  
Group Sample KIR2DL4 KIR2DS1 KIR2DS2 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 
Total 
aKIRs  
1 Sample 1 yes no no no no yes no 2 
1 Sample 2 yes no no no no no no 1 
1 Sample 3 yes no no no no no no 1 
1 Sample 4  yes no no no no no no  1 
1 Sample 5  yes no no no yes no no 2 
2 Sample 6  yes no yes yes yes no yes 5 
2 Sample 7  yes yes no yes yes yes yes 6 
2 Sample 8  yes no yes yes no  yes  yes 5 
2 Sample 9  yes no yes no yes yes yes 5 
2 Sample 10  yes no yes no yes yes yes  5 
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3.3 ZN staining of M.tb H37Rv  
 
 Figure 3.2: Light microscope image of M.tb H37Rv after ZN staining.  
 
Figure 3.2, shows the ZN staining of M.tb H37Rv to determine the purity of the culture.  As seen in the 
figure, only bright red bacilli were present, indicating a pure culture, free of other bacterial 
contaminants.
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3.4 Assessing the purity of the isolated NK cell populations using 
FACS 
The signal-to-noise-ratio for each antibody was calculated and antibody titration curves were plotted 
to determine the saturating concentration.  The saturation points are indicated in figure 3.3.  At this 
point there is an optimal separation of the negative and positive populations. These points represents 
the concentrations that will generate specific staining with the least amount of background noise.  
 
              
 
           
Figure 3.3: Antibody titration plots.  The evaluation of different antibodies volumes by staining PBMCs with 
each antibody.  The dots in red show the optimal concentration, which was used for further FACS analysis. 
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Figure 3.4: Gating strategy. (A) Time gating was included to check for any instrument interruption. (B) Single 
cells were included using forward-scattered height (FSC-H) vs forward-scattered area (FSC-A). (C) The 
lymphocyte population was selected using FSC-A and side scatter area (SSC-A). (D) The CD3 negative 
population was selected. (E) The CD3 negative population was further subdivided into CD3- cells expressing 
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The percentage of CD3- cells was determined using the gating strategy indicated in figure 3.4.  Data 
were plotted versus time to visualize the cell flow.  This was used to control for any unstable flow of 
cells and to ensure that there were no interruptions.  Thereafter single cells were identified by gating 
on forward scatter-height (FSC-H) versus forward scatter-area (FSC-A).  The lymphocyte population 
was then selected and divided into CD3- cells.  This was further divided into CD56+ and CD56- 
populations.  The isolated NK cell population purities varied between 40% and 88% (mean = 69.95 ± 
SD = 14.74). The frequencies of CD56+ and CD56- within the isolated NK cell populations are 
indicated in table 3.3. 
 
Table 3.3: The purity of the isolated NK cell populations.  The frequencies of the CD56+ and CD56- cells within 
the NK cell populations is indicated in the last two columns.  Frequencies were calculated based on FACS results 
obtained with the FlowJo® V10 program. 
 
Sample  
Purity of NK cell 
population (%) 
 
CD56+  (%) 
 
CD56-  (%) 
Sample 1 74.6% 94.9% 5.14% 
Sample 2 86.3% 97.0% 2.99% 
Sample 3 70.8% 93.7% 6.29% 
Sample 4 39.6% 96.3% 3.66% 
Sample 5 73.0% 86.5% 13.5% 
Sample 6 85.6% 96.0% 4.01% 
Sample 7 52.4% 93.8% 6.25% 
Sample 8 68.9% 94.3% 5.70% 
Sample 9 87.6% 98.9% 1.10% 
Sample 10 60.7% 64.9% 35.1% 
 
The fraction of NK cells in the PBMC populations as well as the amount of NK cells that were isolated 
for each sample differed.  Figure 3.5 is a representation of two samples.  The graphs of the remaining 
samples are shown in appendix IV.  Some of the isolated NK cells were still attached to the magnetic 
particles after the NK cell isolation.    
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Figure 3.5: Panel A shows the NK cell counts of Sample 3 in the two different cell populations and the Non-
NK cell fraction. The natural killer (NK) cell counts within the NK cell population are indicated in light orange, 
the NK cell counts within the non-NK cell fraction are indicated in blue and the NK cell counts within the PBMC 
population are indicated in red.  Panel B shows the NK cell counts for Sample 5. Graphs were made using the 




 Sample Name  Subset Name Count  
 Sample 3-NK cells CD3- 2290 
 Sample 3-non-NK fraction CD3- 819 
 Sample 3-PBMC CD3- 26080 
 Sample Name  Subset Name  Count 
 Sample 5-NK cells  CD3- 3305 
 Sample 5-non-NK fraction CD3- 16139 
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                                                                                                                Comp-APC-A::CD56 
Figure 3.6: Gating strategy to identify the presence of other cell populations. (A)  The CD3 population was 
selected by gating for CD3+. (B) The cytotoxic T cells and Th cells were subsequently selected. (C) Number of 
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After assessing the purity of the isolated NK cell populations, FACS analysis was done to determine 
whether other cell types were present.  The gating strategy is indicated in figure 3.6.  Cytotoxic T cells, 
Th cells and NKT cells were identified (Table 3.4).  The frequencies varied between the samples, 
however, cytotoxic T cells were constantly found at a higher frequency when compared with the Th 
cells (14.32% vs 5.7%).  
 
Table 3.4: The frequencies of other cell types observed within the isolated NK population.  Frequencies were 
calculated based on FACS results obtained with the FlowJo® V10 program. 
Sample 
T cells  
(CD3+) 
Cytotoxic T cells 
(CD3+ CD8+) 
T helper cells 
(CD3+ CD4+) 
NKT cells  
(CD8+CD56+) (CD4+CD56+) 
Sample 1  25.2% 56.6% 26.3% 80% 89.4% 
Sample 2  12.7% 6.83% 3.41% 100% 100% 
Sample 3 27.8% 12.2% 1.78% 100% 100% 
Sample 4  59,9% 4.05% 0.95% 95.6% 95.3% 
Sample 5 25.5% 3.03% 1.38% 100% 82.9% 
Sample 6 12.2% 21.3% 3.56% 92.7% 95.6% 
Sample 7  47.1% 6.35% 2.04% 100% 100% 
Sample 8  26.2% 7.13% 0.30% 94.8% 100% 
Sample 9  10.8% 22.6% 7.80% 90.1% 94.7% 
Sample 10  40.20% 3.08% 3.16% 80% 90% 
 
The CD56dim subset was increased compared to the CD56bright subset within each isolated NK cell 
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Table 3.5: The total counts of the CD56-, CD56dim and CD56bright subsets. 
Sample CD56- CD56dim CD56bright 
Sample 1 33.8 56.4 5.75 
Sample 2 23.2 66.7 5.00 
Sample 3 13.1 79.1 3.59 
Sample 4 34.6 50.8 3.20 
Sample 5 35.8 41.8 4.11 
Sample 6 20.8 72.7 2.20 
Sample 7 18.0 75.2 3.87 
Sample 8 7.54 89.3 1.94 
Sample 9 40.7 33.0 2.75 
Sample 10 32.9 48.6 0.38 
 
  
            
 
Figure 3.7: Gating strategy for identifying NK cell subsets.  The CD3 negative population was 
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3.5 Assessing the mycobacterial killing capacity of the NK cells.  
No significant difference in mycobacterial killing efficiency was found between the two groups (p = 
0.57, Figure 3.8).  In addition there was no significant association found between the CFU counts and 
the NK cell purity (p = 0.17), NK cell subsets (p = 0.12) or stimulation time (p = 0.14).  Even though 
no statistical significant difference was found, it was visually observed that the growth of M.tb H37Rv 
was less when NK cells and hIL-2 was added compared to the control (M.tb H37Rv, without NK 
cells/hIL-2).  This difference was not observed when comparing the NK cells stimulated with M.tb 
H37Rv only versus cells that were stimulated with hIL-2 and M.tb H37Rv (data not shown). 
  
 
Figure 3.8: Mycobacterial killing efficiency of NK cells isolated from group 1 (aKIR < 5) and group 2 (aKIR 
≥ 5) individuals. Stimulations were done at 1 hour and 24 hours. Group 1 is indicated in red and group 2 is 
indicated in green.  Graph shows means and SD readings from 10 individual experiments performed in 
triplicates.  The y-axis indicates the CFU count and the x-axis the time points. CFU, colony forming units.  
 
3.6 Cytokine quantification 
The expression of RANTES, perforin, IL-17A, IFN-γ and granzyme B after M.tb H37Rv stimulation 
was determined in the culture supernatant using a Luminex immunoassay platform. 
 
3.6.1 The effect of the number of aKIRs on cytokines expression  
  
A higher expression was observed for RANTES, perforin, IL-17A and IFN-γ in group 2 (Figure 3.9). 
However only the difference in RANTES expression between the two groups was significant (p = 0.04) 
(Figure 3.9A).  Granzyme B expression, however was higher in group 1, but this was not statistically 
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significant (p = 0.12). The observations indicated in figure 3.9 were only when no other factors 
(stimulation types/time) were taken into account.  
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Figure 3.9:  The Least Square (LS) means of cytokine expression between the KIR groups. Vertical bars denote 
0.95 confidence intervals. (Different letters between two vertical lines indicate statistical significance) (A) 
RANTES, (B) Perforin, (C) IL-17A, (D) IFN-γ , (E) Granzyme B.
*RANTES LS mean  
*Perforin LS mean  
*IL-17A LS mean  
*IFN-γ LS mean 
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Figure 3.10: The LS mean of cytokine expression, taking KIR group and stimulation into account. Vertical bars 
denote 0.95 confidence intervals. (Different letters between two vertical lines indicate statistical significance). 
(A) RANTES, (B) Perforin, (C) IL-17A, (D) IFN-γ , (E) Granzyme B.  
         Group 1 
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Figure 3.10 shows the comparison of cytokine expression between group 1 and group 2 following 
stimulation with either M.tb H37Rv or M.tb H37Rv+ hIL-2.  All of the investigated cytokines, with the 
exception of granzyme B showed a higher expression when stimulated with M.tb H37Rv only.  
RANTES expression remained increased in group 2, compared to group 1, after the type of stimulation 
was taken into account; however this was not statistically significant (p = 0.37).  A significant 
difference between the two different stimulations was observed for IL-17A in group 2 (p = 0.05) 
(Figure 3.10C).  Increased IL-17A expression was observed after M.tb H37Rv only stimulation within 
group 2 (mean = 1.39; SE = 0.16).  
 
Furthermore when taking into account the time points and stimulation types, perforin expression was 
significantly higher at 1 hour (mean = 14.04; SE = 3.77) compared to the 24 hour time point (mean = 
7.21; SE = 3.77), when stimulated with M.tb H37Rv only (p = 0.02).  When stimulated with M.tb 
H37Rv+ hIL-2, no difference was observed between the two time points as indicated in figure 3.11A. 
Granzyme B expression was also higher at 1 hour when stimulated with M.tb H37Rv only, however 

























































Figure 3.11: The LS means of the cytokine expression and the influence of stimulation and time on the 
expression. Vertical bars denote 0.95 confidence intervals. (Different letters between two vertical lines indicates 
statistical significance).  (A) Perforin, (B) Granzyme B.  Stimulations with M.tb H37Rv is indicated in blue; 
M.tb H37Rv+hIL-2 is indicated in purple. 
 
Figure 3.12 indicates how cytokine expression are affected when taking into account, KIR genotype, 
stimulation type and time.  Group 2 had an increased RANTES expression compared to group 1, with 
the highest expression observed 24 hours after stimulation with M.tb H37Rv only (Figure 3.12A).  This 
was also the case for IFN-γ expression 24 hours after stimulation with M.tb H37Rv; however for group 
1, expression was higher at the 1 hour time point when compared to the 24 hour time point when
A B 
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stimulated with M.tb H37Rv only.  None of these observations were statistically significant.  Higher 
granzyme B expression was observed for group 1 when stimulated with M.tb H37Rv at both time points 
when compared to group 2.  However, overall, no third order interaction was observed significant for 













































































Figure 3.12: LS means of cytokine expression when taking KIR group, stimulation and time into account. (A) 
RANTES, (B) IFN-γ, (C) Granzyme B.
     Stimulation  
        M.tb H37Rv  
        Stimulation  
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Chapter 4: Discussion  
 
Susceptibility to M.tb infection and disease progression depends on the complex interaction between 
host genetic factors, the causative pathogen and the environment.  It is known that a great majority of 
individuals never develop active TB disease after infection with the causative pathogen21.  Despite 
intensive scientific investigations, the exact factors contributing to this favourable outcome still remain 
unknown.  Genetic epidemiology studies have provided robust evidence that genetic variants contribute 
to TB susceptibility, but functional verification of these statistical associations have not received the 
required attention.  It was previously found that individuals with five or more aKIRs are protected from 
developing active TB22.  In this study we therefore aimed to compare the mycobacterial killing 
efficiency of NK cells, isolated from individuals with less than five aKIRs (group 1), to that of 
individuals with five or more aKIRs (group 2), and to characterise the cytokine expression profiles of 
the NK cells after stimulation with M.tb H37Rv or M.tb H37Rv+hIL-2.   
 
4.1 KIR genotypes 
 
It is well known that KIRs are highly polymorphic, that unrelated individuals rarely have identical KIR 
genotypes and that ethnic groups differ remarkably in the distribution of KIR genotype 
frequencies227,228.  KIRs are one of the main receptor superfamilies expressed on NK cells.  During 
development, NK cells are programmed to express unique combinations and numbers of KIRs resulting 
in the clonal diversity of receptors on NK cells in peripheral blood201.  Five hundred and ninety four 
different KIR genotypes have been reported in populations worldwide and it is believed that this 
diversity may alter the susceptibility/resistance to a number of pathogens through ligand-receptor 
interactions as well as through cytokine release229–231.  The first objective of this study was to identify 
individuals with five or more aKIRs and individuals with less than five aKIRs.  Thirty individuals were 
genotyped, of which 17% had five or more aKIRs.  This frequency of aKIRs correlates with a previous 
South African study22.  South Africa is known to be culturally diverse, with four predominant ethnic 
groups, namely the Black South African, Caucasians, South African Coloured and South African 
Indian232.  Each of these population groups have their own distinct demographic history.  The ethnicity 
of the participants selected within the two groups were the same since it is known that KIR genes vary 
between ethnically and geographically distinct populations and would therefore influence the 
outcomes233–236. 
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The KIR2DL4 gene is unusual since it contains a cytoplasmic ITIM, which is a feature typical of 
inhibitory KIR as well as a positively charged amino acid in the transmembrane region, suggesting an 
activating function.  This gene has inhibitory as well as activating functions.  A previous study has 
shown that the cytoplasmic domain of KIR2DL4 can exhibit a strong Src homology 2 containing protein 
tyrosine phosphatase (SHP) 1 independent inhibitory function in isolation when the 2DL4 
transmembrane arginine residue is mutated or when fused to the extracellular transmembrane domains 
of KIR3DL1237,238.  On the contrary it has been shown that the engagement of KIR2DL4 on resting cells 
results in IFN-γ production and IL-2 activated NK cells respond to KIR2DL4 by increasing both IFN-
γ and cytotoxicity239.  It was also found that this gene does not have a strong inhibitory signal when 
compared to other iKIRs, like KIR3DL1 and that some activation potential was observed for 2DL4 
isoforms that lacked the cytoplasmic ITIM, indicating that ITIM doesn’t influence the activating 
function240.  Possible reasons for this are the presence of only a single ITIM and the context of the 
unique KIR2DL4 cytoplasmic tail, which may dampen the inhibitory function of the ITIM238.  There 
for KIR2DL4 gene was defined as an aKIR in the current study.  Furthermore this study is based on 
work done by Salie et al. which included this gene as an aKIR22.  However, since the gene was present 
in all the individuals in group 2 it could have been possible to exclude it and adjust the cut off four or 
more aKIRs (2DS1, 2DS2, 2DS3, 2DS4, 2DS5 and 3DS1) for group 2.  
 
Salie et al. identified a protective effect for the number of aKIR genes in the SAC population.  In 
addition to this, these researchers showed that individuals with a copy of the KIR3DS1 gene were less 
likely to develop active TB22.  In contrast to this finding, the presence of the KIR3DS1 gene was 
associated with TB susceptibility in the Lur population (China)241 and in the Chinese Han 
population242.  These findings suggest that this gene has diverse effects across ethnicities or could be 
in linkage disequilibrium with the true disease-contributing gene or variant.  In our cohort, none of the 
individuals in group 1 had a copy of the KIR3DS1, while participants in group 2 all carried the gene. 
This study did not investigate haplotypes but it is known that haplotype A consists of one aKIR (2DS4) 
whereas haplotype B has five or more aKIRs (2DS1-2DS5 & 3DS1)226.  This correlates with the absence 
of KIR3DS1 gene in our study participants. The predominant haplotype observed within this study was 
haplotype B.  This correlates with the study conducted by Salie et al.22 .  No statistically   significant 
difference was observed for the killing of mycobacteria between the two groups and therefore it can be 
said that no protective effect was observed for the KIR3DS1 gene, however this should be further 
investigated in a larger sample set. 
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KIR2DS4 is the only aKIR gene present on haplotype A and two different amplicon sizes can be 
obtained with this gene.  The variant of KIR2DS4 gene has a 22bp deletion in exon 5243.  Therefor when 
219bp product gets detected when the primer pair in exon 5 is amplified it means that the full length 
gene is present.   However when a 197bp is detected it means that the deletion variant is present.  The 
two types of allele are distributed unequally in different populations244.  The deletion allele is frequently 
(80%) observed within Caucasians. This would suggest that A-haplotype homozygotes of this ethnicity 
often have no aKIR, besides KIR2DL4245.  The majority of individuals would therefore be expected to 
have at least one copy of this gene.  In this study we only determined whether KIR2DS4 was present 
and did not investigate the size of the fragment.  The gene was observed with a frequency of 80% in 
the overall cohort. However; only 50% of the 10 selected individuals carried this gene which was not 
expected.  Possible reasons for the low observation of KIR2DS4 within the 10 selected individuals can 
be because of possible failed assays.  It would have been of interest to determine the size of the gene 
fragments by using QIAxcel automated gel electrophoresis system (Qiagen, USA)246,247.  Previous 
studies also used a nested PCR to isolate KIR2DS4 alleles with and without the known exon 5 
deletion248.  This method was not used in the current study and therefore it is possible that some alleles 
of KIR2DS4 were not detected.  The PCR-SSP method used in this study is simple and robust but have 
the drawback of relying on the amplification of DNA fragments spanning from 0.5-2k bps, which tends 
to fail in low-quality DNAs244.  However; a positive control was used, which showed that the DNA 
quality of the samples were not low in quality.  
 
The KIR genotypes were determined based on the absence/presence of KIR genes.  Thus the copy 
number of the genes were not taken into consideration.  The expression of KIR genes on NK cells are 
random and is determined by polymorphisms, gene content and stochastic epigenetic regulation at 
promoter level249.  The underlying impact of KIR copy number variation (CNV) on human NK cell 
repertoires and functionality remains unknown249.  CNV leads to considerable diversity for B 
haplotypes, but not for A haplotypes250.  There for individuals carrying a duplication/deletion of genes 
on A haplotypes would have no selective advantage whereas extreme B haplotypes containing between 
four and 15 genes are consistent with a survival advantage of variability250.   In this study we did not 
consider CNV, but it would be of interest since CNV can lead to expression differences which may be 
important to susceptibility to some diseases.  For example  CNV of 3DLS1 influences HIV control and 
it has been found that expression differences of 2DL3 interacting with HLA-C also may have an effect 
on resolution of hepatitis C virus infection251,252.  
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A previous study also found that individuals with multiple KIR gene copies had higher frequencies of 
responding cells249.  Copy number can be measured using a quantitative PCR comparative Ct 
method210,253.  Furthermore variations between individuals in the repertoire of KIR alleles expressed 
can also be associated with differences in response to pathogen associated signals.  
 
4.2 NK cell isolations   
 
NK cells were isolated from PBMCs using a negative selection kit.  Using this method for the isolation 
of cells results in “untouched” cells that are suitable for functional assays.  However, obtaining pure 
isolated cells is challenging because it requires the design of the perfect depletion cocktail that is 
specific only to the cells of interest and will result in high purity.  It has been shown that the purity of 
isolated NK cells varies (51.50% - 81.97%) depending on the kit used, despite the kits employing the 
same underlying method254.  Therefore the negative selection method that was used in our study might 
have affected NK cell purity.  
 
The purity of the isolated NK populations for the samples in this study varied from 40% to 88%.  This 
variation between the samples (even though the same technique and kit was used) can be due to various 
reasons.  The NK cell content within the PBMCs of each sample varies and purities might be lower 
when starting with samples that contained less than 10% NK cells255.  Additionally, PBMCs were 
cryopreserved prior to NK cell isolation.  Cryopreservation has been shown to influence the percentage 
of NK cells256 and the cytotoxic function of these cells in some studies257,258, while in others no effect 
was detected259,260.  Therefore, the exact consequences of using cryopreserved PBMCs remains 
unclear.  However, the cryopreservation of the PBMCs in this study was required for its successful 
execution.   
 
To determine whether other cell types were present within the isolated NK cell population, further 
gating was done (Section 3.4). The presence of T cells were investigated by selecting for CD3+ 
expression markers.  Both cytotoxic T cells (CD8+) and T helper cells (CD4+) were identified within 
the CD3+ T cell gate.  The presence of these cell types following negative selection may be due to the 
ability of NK cells to express CD8 and CD4 markers261,262.  Although it is unknown exactly which 
antibodies were used in the EasySep™ Human NK isolation cocktail due to proprietary reasons, it is 
possible that since NK cells can also express CD4 and CD8 that anti-CD4 and anti-CD8 antibodies are 
not present.  
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Subsequently, these cell types could not have been labelled and therefore not effectively removed.  
Alternatively, lymphocyte receptors for antigens are derived by a stochastic process and therefore 
recognition of epitopes by receptors will never be absolute263,264.  NK cells can be subdivided into two 
major subsets, namely CD56brightCD16dim and CD56dimCD16bright, based on the relative expression of 
their surface markers.  We determined the frequencies of the two subsets in PBMCs from each 
participant and found that the CD56bright subset was consistently lower than the CD56dim subset.  The 
mean was 3.28% for the CD56bright subset and 61.36% for the CD56dim subset.  This was expected since 
it is known that the major circulating NK cell subset in blood of healthy individuals is 
CD56dimCD16bright  with a frequency of 90% and a maximum of 10% for the CD56bright 82,265.  It is also 
known that the proportion, numbers and subset frequencies of NK cells can differ between individuals 
due to age, ethnicity and gender266–268.  It has been shown that the CD56bright subset decreases with age 
whereas the CD56dim subset increases, however, this was not observed in this study266,269.  The 
participant ages in this study did not differ significantly between the groups and no participant was 
older than 50 years or younger than 21.   
 
Peripheral blood is complex since it contains a variety of cell types and the relative proportions of these 
cell types can also differ tremendously between individuals270.  It is known that PBMCs only contain 
a small fraction (up to 15%) of NK cells which add to the complexity of isolating these cells81.  Even 
though there was a variation in purity this did not significantly influence the outcomes of the killing 
capacity between the two groups (Section 3.5)  
 
4.3 Mycobacterial killing capacity of NK cells  
 
The second objective of this study was to determine whether NK cells expressing five or more aKIRs 
are more efficient at killing mycobacteria compared to NK cells with less than five aKIRs.  NK cells 
were initially only thought to be vital against viral infections and cancers, now however, it is widely 
accepted that these cells play a crucial role in protection and control of bacterial infections65,85,91.  The 
two main effector responses of these cells are their ability to be cytotoxic and produce cytokines99. 
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4.3.1 Cytotoxicity 
Stimulation of NK cells was done using M.tb H37Rv (in the presence or absence of hIL-2) and CFUs 
were counted to determine the killing efficiency of the NK cells between groups 1 and 2.  No statistical 
significant difference was found when comparing the killing efficiency of NK cells from individuals 
in group 1 with that of the individuals in group 2.  It was observed that the growth of M.tb H37Rv 
decreased in the presence of NK cells and hIL-2.  This study possibly had too few samples for statistical 
purposes since it is known that there is a lot of variance when looking at CFU counts.  Therefore more 
samples will lead to less variation and as a result, higher confidence.  
 
It is known that human NK cells mediate the killing of intracellular mycobacteria within the first 24 
hours of co-culture with infected monocytes97,  while other studies also showed that NK cells inhibited 
intracellular growth of avirulent strains, H37Rva and M.avium131,271.  In the present study, we did not 
make use of co-cultured infected monocytes and stimulations were done using extracellular M.tb 
instead.  NK cells can interact directly (in the absence of antigen specific T cell response, APC, IL-12) 
with various pathogens, including M.tb, which promotes NK cell activation109,192,272,273.    
 
Previous studies that investigated direct interactions between NK cells and mycobacteria observed that  
receptors, such as the NKp44 receptor is involved in the direct binding274.  It is uncertain how KIRs 
interact directly with mycobacteria.  Therefore it would have been of interest to determine the 
activation states of the cells by looking at differentially expressed surface markers.  The NK cells for 
this study mostly had a mature phenotype since the dominant subset within both groups in the isolated 
NK cell populations was the CD56dim subset.  This subset is known to be more involved in cytotoxic 
killing compared to the CD56bright subset90.  In this study the NK cell subsets did not significantly 
contribute to the outcomes of the NK cells killing efficiency between the two groups.  The functions 
of the different NK cell subsets can be affected by diverse cellular microenvironmental signals98.  It is 
known that the functional response of NK cells depends on the recognition of soluble factors (pro-
inflammatory cytokines) as well as the ligands expressed on the cell surface of target cells275,276.  
Therefore, signals from the microenvironment are integrated by NK cells. The cellular 
microenvironment in our study did not reflect the “normal” cellular microenvironment of NK cells 
within peripheral blood.  This may be a reason why no significant differences were detected between 
the killing capacity of the cells since it is known that in peripheral blood the abundance of stimulatory 
cytokines may be needed to maintain NK cells in the cytotoxic state to combat infections98.  The purity 
of the isolated NK cell populations varied between 40–88% and therefore other cell types were present.  
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However, the cell types other than NK cells, that were present, are possibly not the cell types needed 
for NK cells to effectively function.  Even though it has been shown that M.tb is sufficient stimulus to 
promote NK cell responses without other immune cells or accessory derived cytokines it has been 
shown that activated DCs and T cells are needed to secrete abundant IL-2,-12,-18 and -21 which will 
drive NK cell activation as well as their ability to kill98.  
 
It is also possible that the varying outcomes of studies investigating the killing efficiency of NK cells 
are due to differences in virulence between the strains.  Most of the studies that found direct 
associations used attenuated strains rather than M.tb H37Rv, therefore it is possible that stimulating 
with different strains might lead to different NK cell effector outcomes109,111.  The time of the 
stimulations may also have an effect.  In this study stimulations were only done for 1 hour and 24 
hours.  This correlates with some studies97,111, whereas other studies had longer stimulation time points’ 
varying from 48 hours up to three days110,113.  A previous study found that NK cells stimulated with 
IL-2 and M.bovis BCG resulted in progressive release of IFN-γ up to 72 hours co-culture.  However; 
the addition of M.bovis BCG after the first 48 hours culture in the presence of IL-2 did not affect the 
ability of the NK cells to lyse their target cells and a decrease in cytotoxicity was observed after 72 
hours mycobacterial exposure113.  Furthermore, another study found that when monocyte depleted cell 
populations were directly cultured with live bacteria, a marked proportion of NK cells were detected 
among the responding cells. The starting from 3-4 days in vitro stimulations110.  
 
NK cells interact with various other immune cells.  Human NK cells lyses M.tb infected macrophages 
in vitro resulting in the production of IFN-γ and IL-22 from CD8+ T cells and the enhancement of 
phagolysomal fusion which inhibits intracellular growth of M.tb182,277,278.  Therefore, the efficient 
killing of mycobacteria by NK cells can be strongly influenced by the presence or absence of other 
immune cells.  The immune system is very complex and interlinked.  While it is clear that other factors 
also have a vast effect on the killing ability of these cells this goes beyond the scope of the study.   
 
The killing ability of NK cells is known to be stimulated by IL-12106,271,275.  However in the current 
study NK cells were stimulated with a low dose of hIL-2. This cytokine was first identified as a T cell 
growth factor279,280.  IL-2  is derived from activated T cells and can enhance NK cell response toward 
infection in vivo and can activate NK cells in vitro281,282.  Another study showed that NK cells are 
incapacitated in IL-2-β -/- mice, suggesting that this cytokine may have an important role in maintaining 
NK cells activity283.  
Stellenbosch University  https://scholar.sun.ac.za
  Chapter 4: Discussion 
Page | 72  
 
 
Comprehensive activation of NK cells is needed for NK cells to fulfil their roles as sentinels.  IL-2, -
15, -12, -18 and -21 all play a role in activating NK cells195.  The stimulation of the NK cells with hIL-
2 was therefore expected to increase the cytotoxic function.  Nevertheless this was not observed when 
comparing the NK cells that were stimulated with M.tb H37Rv only versus cells that were stimulated 
with hIL-2 and M.tb H37Rv.  A relatively low concentration was used to stimulate the cells so even 
though this cytokine has the capacity to stimulate and quantify a response, the low dose (50U/mL) 
might not have been sufficient to activate NK cells.  Previous studies have used much higher doses 
ranging from 100 – 500U/mL284–286.  Furthermore it is possible that the cells acquire additional signals 
since it has been shown that the expansion of NK cells are much higher in the presence of other cell 
types, including monocytes284,287.  Even though no significant difference was found between the killing 
efficiency of NK cells expressing five or more aKIRs versus those expressing less, this is the only 
functional study thus far that attempted to link the number of aKIRs with the outcomes of the 
mycobacterial killing capacity of the cells.  
 
Lastly, genetic association studies may produce varying results in different populations.  Evidence 
shows that differences in disease outcomes and inflammation between human populations can be 
attributed to genetic diversity in populations288–290.  The genes that are known to be the most diverse 
within the human genome are involved with immune responses291.  Significant genetic influences on 
both humoral and cell-mediated responses have been observed36.  The highly polymorphic and or 
clustered characteristics of immune response genes can be an indication of evolutionary pressure and 
selection292.   
 
One of the characteristic features of the MHC region is the fact that it is polymorphic which contributes 
to a wide range of variation.  This feature is essential for the host to respond to several pathogens since 
the peptide grooves are coded for by these polymorphic regions293,294.  Furthermore most human KIRs, 
which are also highly polymorphic, are specific for polymorphic determinants of HLA class I 
molecules.  This adds to the complexity of understanding and studying KIR genes because the role that 
these genes play in disease susceptibility will be greatly influenced by the HLA class I molecules. 
 
4.3.2 Cytokine expression  
Another reason why NK cells are important in innate immunity is due to their ability to produce a 
variety of cytokines and chemokines.  The CD56bright subset is commonly known as the cytokine 
producing subset of the NK cells.   
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Cytokines that are produced affect the functions of other cell types as well as the survival of the cells 
itself and mediate in part their cytotoxic function. The outcome of M.tb infections are also largely 
determined by the cytokines that are present and cytokine production influences both innate and 
adaptive immunity295.  Therefore, the third objective of this study was to quantify the cytokines 
produced after mycobacterial stimulations and to determine if the expression levels of the cytokines 
are influenced by the number of aKIRs present.  Identifying a possible link between innate and adaptive 
immunity through cytokines that are produced by NK cells may lead to possible new designs of 
adjuvants and vaccines against TB.   
 
It has been proposed that a decrease of aKIRs expression on NK cells can lead to insufficient production 
of M.tb killing cytokines296.  Varying outcomes of immune-regulated diseases between different 
populations have been observed which can also be due to differential expression of cytokines297.  This 
adds to the variation of the effect of cytokines as well as the complexity of the network through which 
NK cells help to control M.tb infection.  Even though we found no statistical significant difference in 
expression due to the amount of aKIRs, a higher expression was still observed for all the cytokines, 
except for granzyme B.  This may be because the sample size was too small to observe any significant 
difference between the groups.  It would thus be necessary to repeat this pilot project with additional 
samples.  Furthermore, baseline controls can also be used to compare cytokine expression before and 
after the stimulations.  It is also possible that the minimal requirement for cytokine secretion was not 
met.  Cytokine expression in vivo is influenced by various factors including, immune complexes, cell-
cell contact, microbial species and other types of cytokines.  Therefore to determine cytokine 
expression in vitro is complex and difficult.  The longest infection duration in this study was 24 hours 
and it is possible that this was not long enough for significant cytokine production.  It would therefore 
be of interest to include longer infection time points.  Moreover, comparing cytokine expression within 
active TB cases to cytokine expression within healthy controls will give insight into which cytokines 
play important role in the immune response to M.tb.  Hence investigating the expression of cytokines 
derived from active TB cases would also be of importance. 
 
The immune system’s cellular components cross-talk through cytokines, thus cytokines play an 
essential role in modulating the immune cell function298.  Chemokines are also important for an 
effective inflammatory response due to their ability to modulate and promote leukocyte migration298.   
RANTES, also known as (C-C motif) ligand 5 (CCL5), is a chemokine produced by NK cells.   
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We found that RANTES expression was significantly higher in group 2 when compared to group 1.  
Chemokine production is an early feature of NK cell responses and can be triggered with relatively 
weak activating signals and requires less stimulation than what is needed for cytokine production115. 
Therefore this might contribute to why only a statistical significant increase was observed for RANTES 
expression and not for any of the cytokines investigated.  Furthermore, CCL4, CCL5 and CCL22 are 
produced by NK cells in vitro without any stimulation299–301.  CC chemokine receptors, like CCR1 until 
9, are not significantly expressed on the surface of resting NK cells.  However NK cells express CCR2, 
-4, -5 and CCR8 after activation with IL-2 or IL-15 in vitro302.  Therefore, we would have expected to 
see an increase in RANTES expression after stimulation with hIL-2; however this was not observed, 
possibly due to low dose stimulation.   
 
The fact that RANTES expression was significantly higher in the group with more than five aKIRs 
(group 2) can possibly contribute to the mechanism that individuals with five or more aKIRs are more 
protected against developing active TB disease, since this chemokine has been found to stimulate 
greater levels of killing298. However this was not consistently observed throughout previous 
studies303,304.  Furthermore CCL2 - 8 have been shown to promote cytotoxic granule release by resting 
polyclonal NK cells305,306.  The concentrations of these chemokines that causes the stimulation of 
granule exocytosis were similar to those that enhance NK cell cytolytic activity.  We therefore 
speculate that chemokines increase NK cell lysis of target cells by facilitating the discharge of NK cell 
cytotoxic granules306.  
 
Both granzyme B and perforin are known to be the major cytotoxic proteins that are contained within 
the NK cells.  These cytotoxic granules in NK cells are preformed before cell activation, therefore a 
balance of inhibitory and activating receptors are important for immunosurveilance307.  NK cell lytic 
synapse occurs before molecular patterning is completed and molecular reorganization at the synapse 
seems to be dependent on regulatory signals, with signals from KIRs playing an important role as well. 
This regulation ensures that NK cells carry out their surveillance function as effectively as possible307.    
 
Perforin facilitates the entry of granzymes into the target cell cytoplasm; however, this mechanism by 
which this occurs remains unclear.  When an immune synapse is formed between a target cell and NK 
cells, the cytotoxic granules moves into a synaptic cleft and the granzymes are then delivered into the 
target cell307.  
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Granzyme B expression was relatively higher in group 1 compared to group 2.  Perforin is required for 
granzyme delivery into target cells, however less perforin expression was observed within the group 1, 
suggesting it was utilised elsewhere.  This could result in higher granzyme B expression.  The pathway 
for perforin and granzyme B secretion is distinct from cytokine expression since perforin is secreted 
from cytotoxic granules. This mechanism allows NK cells to simultaneously recruit immune cells and 
kill target cells.  The low levels of granzyme B (especially in group 2) and perforin expression may 
also be due to NK cells exhaustion after carrying out their killing functions308,309.  Cytotoxicity is 
mainly achieved through the release of granzyme B and perforin into the immunological synapse and 
therefore a loss of cytotoxicity can be because of  inhibition of these two compounds129,135.  
 
A reduction of granzyme B and perforin content was observed in a previous study after the cells were 
incubated with the target cells135.  In the present study a slight decrease in perforin expression was 
observed at 24 hours when stimulated with M.tb H37Rv only, whereas for granzyme B expression, a 
higher expression was observed when stimulated with M.tb H37Rv + hIL-2 at 24 hours.  Previous 
studies also found an increase in perforin and granzyme B content when cultured with IL-2135.  The 
expression and activation of these two proteins varies between different clonal populations310.  Perforin 
expression differed significantly depending on the time and the type of stimulation.  CD56dim NK cells’ 
perforin expression is 10-fold higher when compared with CD56bright NK cells81.  The current study did 
not differentiate between CD56dim and CD56bright cells when measuring expression.  
 
Another influence on cytokine expression is the multiple cytokine receptors.  Cytokines plus activating 
NK cell receptors provide combined signals which results in robust NK cell effector responses. 
Therefore it is thought that NK cells can change the extent of response and sense differing extents of 
inflammation and pathogenicity67,311.  NK cells were stimulated with a combination of cytokines (IL-
2, IL-15 and IL-12) and a higher IFN-γ secretion was observed when compared to when the cells were 
only stimulated with IL-2301.  In our study IFN-γ expression was lower when stimulated with M.tb 
H37Rv and hIL-2 compared to when stimulated with M.tb H37Rv in the absence of hIL-2.  This might 
be due to the fact that IL-12 was not present, since previous studies found that IL-2 alone cannot 
stimulate the release of IFN-γ.  IL-2 acts synergistically with IL-12 to secret IFN-γ and another study 
found that IFN-γ half-life is increased when both IL-12 and IL-2 are used in combination312.  
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However in other studies, IL-2 directly stimulated IFN-γ production from activated NK cells in the 
absence of other stimuli313,314.  Secretion of IFN-γ in a previous study was tightly controlled and needed 
engagement of multiple different receptors115.  It is therefore possible that resting NK cells need 
supplementary signals to produce detectable levels of IFN-γ.  These additional signals can possibly be 
provided upon cell-cell interaction with accessory cells or additional cytokines315.  Cytokine receptors 
which are expressed on NK cells also play an important role in NK cell effector outcomes when ligated 
through a number of intracellular signalling pathways311.  However this study only focused on the aKIR 
receptors. Previously it was found that individuals with a greater number of aKIRs had a greater 
response to M.tb infection due to an increased IFN-γ release.  IFN-γ is one of the main cytokines 
involved in protection against M.tb since it is known to activate macrophages141.  
 
In this study a slight increase in IFN-γ expression was observed in the group with five or more aKIRs.  
This can explain why individuals with more than five aKIRs were shown to be more protected against 
developing active TB disease even though the higher expression was not statistically significant in this 
study.  It has also been found that regulation of IFN-γ production is dependent on the balance of both 
inhibitory and stimulatory cytokines released from Th1 cells and NK cells152.  In this study no other 
cell types were present, therefore optimal IFN-γ production was not fully observed.  Macrophages were 
shown to be required for IFN-γ production316 and since no macrophages were co-cultured with the NK 
cells in this study, this could explain the low cytokine expression.  It has also been found that the 
production of immunoregulatory cytokines from CD56bright NK cells is dependent on monokine 
stimulations and qualitative differences are seen, depending on the specific monokines that are 
present81.  The effect of exogenous cytokines on NK cells have been well studied.  It is known that NK 
cells can proliferate in response to IL-2, -4, -7, -12 and IL-15317–320  and that IL-2 and IL-15 cause a 
greater  NK cell proliferation compared to other cytokines301.  IL-2 and IL-15 represents the best 
studied cytokine activators of NK cells.  IL-2 is central for NK cell development, homeostasis, 
proliferation induction and enhancement of cytotoxic effector mechanisms.  CD56dim cells express βγ 
common chains of IL-2 and IL-15 receptors. These cells therefore demonstrate an increase in 
cytotoxicity, proliferation and cytokine secretion after stimulation with IL-2 or IL-15. Whereas 
CD56bright cells  express high affinity αβγ heterodimers and proliferate with IL-2 alone and produce an 
abundance of IFN-γ 321.    
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Resting CD56dim  cells are more cytotoxic against NK sensitive targets than CD56bright cells67,322. 
However when CD56bright  cells were activated with IL-2, an enhanced cytotoxicity against NK targets 
compared to CD56dim was exhibited322. In this study we did not investigate the variation of cytokines 
between NK cell subsets; however this would be of interest in follow up studies, because it is clear that 
the different NK cell subsets are one of many factors that influence NK cells cytokine expression.  IL-
2 and IL-15 also induce IL-17 production in PBMCs323, however in this study IL-17A expression was 
significantly higher in the group with five or more aKIRs when stimulated with M.tb H37Rv in the 
absence of hIL-2. IL-17A contributes to protection against M.tb infections through early neutrophil 
recruitment, enhancing reactive oxygen species (ROS) production and migration of inflammatory cells 
at early stages of infection324–326.  IL-17A increased NK cell number and their cytotoxic function and 
M.tb H37Rv induced IL-17 production in neutrophils which was dependent on IL-6 and IL-23 in 
previous studies112,327.  Clearly optimal cytokine production is influenced by the presence of other 
cytokines. Even though IL-17A contributes to protection against M.tb infection, this cytokine is also 
known to add to the pathogenesis of autoimmune and inflammatory disease.  M.tb infection and 
autoimmune diseases have been found to be related since M.tb is a strong immunogen328.  Therefore 
type-I immunity is essential for protection against microbial pathogens but should be tightly controlled 
since uncontrolled type-1 cellular immune responses can cause immunopathology, tissue damage and 
disease327.  The expression as well as the control of cytokines are important for immunopathology and 
immunity.  
 
4.4 Limitations of the study  
 
Limited sample size  
The first limitation of the study was the small sample size.  Genes encoding iKIRs are nearly always 
present in populations at frequencies greater than 90%; however the frequencies of aKIRs are much 
lower. Therefore to increase sample size, a larger cohort will be needed to increase the amount of 
individuals in group 2.  Furthermore, this was a pilot study and therefore the protocol established, 
during our study to determine the killing efficiency of NK cells against fighting TB infection while 
incorporating the KIR genotype, can be used in a larger scale study. 
 
KIR genotyping  
Some individuals could have more copies of a certain gene when compared to other individuals, since 
the CNV were not determined.  Furthermore, there were no internal positive control for the specific 
primers used during the genotyping method.  Bx genotype with all the genes present would have been 
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beneficial to use as a positive control.  The presence/absence of only seven KIR genes were determined 
but it would have been of interest to genotype all 15 KIR genes. 
 
PBMCs cryopreservation  
The NK cells could only be isolated once all the PBMCs were isolated from the whole blood for each 
sample and since blood was drawn over a period of three weeks, cryopreservation was needed.   The 
fact that the PBMCs had to be cryopreserved before the NK cells could be isolated also made it more 
challenging.  Cryopreservation of PBMCs is a standard procedure even though it can potentially induce 
significant changes in phenotype and/or function.  It has been shown that cryopreservation does not  
have an effect on cells259,260.  However there are studies that found that cryopreservation influence 
PBMCs and the true effects of cryopreservation on NK cells remain unknown256.  A study showed that 
after standard freezing and thawing of PBMCs, the percentage of CD56+CD3- NK cells did not 
change329.  The percentage of viable active NK cells also stayed consistent, however it seemed that the 
cytotoxic function of the these cells were reduced257,258.  After the thawing process, the initial amount 
of viable PBMCs decreased, which resulted in a decrease in the number of NK cells that could be 
isolated.  
 
NK cell isolations  
Isolation of NK cells from PBMCs is complex because peripheral blood only contains a small fraction 
of NK cells. This study required the isolation of “untouched” NK cells and therefore a negative 
isolation kit was used instead of a positive isolation method.  Negative isolation leaves the NK cells 
“untouched”, however it is more difficult to isolate a pure population of cells.  Additionally the FACS 
analyses showed for some samples the NK cells were still attached to the magnetic that also contributed 
to decreased numbers of isolated NK cells.  The culturing of NK cells is challenging and it was not 
feasible to obtain viable NK cells for longer than 24 hours without stimulation.  We therefore stimulated 
the cells with hIL-2254.  It is known that hIL-2 causes a change in the phenotype of NK cells and can 
also affect the function of the cells85.  Downstream experiments in this study were therefore done with 
and without hIL-2.  
 
Determining mycobacterial survival.  
CFU counts were used to determine the mycobacterium’s viability.  Two advantages of using this 
method, only viable bacteria are counted and this method has the capacity for counts of any number of  
bacteria; however disadvantages of using this method, takes ± 3 weeks to obtain results, not very 
reproducible and count can be affected by minor bacterial clumps330.  
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Therefore, the LIVE/DEAD® Baclight Bacterial viability kit 
(https://www.thermofisher.com/order/catalog/product/) or cytotoxic assays can be used to determine 
NK cells killing efficiency.  These techniques might better represent the mycobacterium’s viability.  
 
HLA class I genotyping  
Another limitation of this study was that the HLA genes of the participants were not taken into 
consideration since it is known that most human KIRs are specific for HLA class I molecules331. 
Therefore, the HLA class I molecules will greatly affect the role of KIR genes in disease susceptibility.   
It is known that the HLA region is the most polymorphic in the human genome332.  Since this was a 
pilot study, including another factor into the analysis would have decreased the study power. 
  
Determining cytokine expression 
TNF-α, GM-CSF and IL-10 were excluded from the analysis due to missing and out of range (OOR) 
data.  Higher sample volume would be needed for the samples that were OOR due to low signal for the 
standard curve.  However when OOR data were observed due to samples containing analyte 
concentrations higher than highest standard point, the sample can be diluted and reanalysed for that 
analyte.  Furthermore, we could not compare how cytokine expression differed between baseline and 
after infections because of the limited amount of NK cells isolated from PBMCs. 
 
4.5 Future studies  
 
If proven that individuals with more aKIRs are protected against developing active TB, follow up 
studies can be done to find the mechanism behind this effect.  The effector functions involved and the 
exact role that more aKIRs play in the immune response against M.tb can be further investigated. 
Furthermore cotransfection and coimmunoprecepitation can be used to determine the association of 
aKIRs and adaptor molecules.  Ligand recognition assays can also be used to determine the involved 
ligand specificity.  In the long run this can be used to manipulate NK cells to generate an increased 
immune protection against developing active TB.   
 
NK cells can be stimulated with M.tb in the presence of an APC, for example, stimulating NK cells in 
the presence of macrophages.  This will facilitate the investigation of the NK killing capacity through 
an indirect pathway.  The Pierce™ Lactate dehydratase cytotoxicity kit (Thermo Fisher scientific, 
South Africa) can be used to measure LDH released into the media from damaged cells as a biomarker 
for cellular cytotoxicity and cytolysis. 
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The point of contact between the NK cells and mycobacteria can also be investigated by using high-
resolution imaging techniques such as super-resolution confocal microscopy and to identify the 
receptors that are involved in the activation of the immune response against M.tb infection. Flow 
cytometry can be used to identify the effect of M.tb stimulation on the expression markers of the NK 
cells and subsets before and after stimulations.  Identifying the effect of M.tb stimulation on NK cells 
can lead to a possible identification of the effect of the infection on the phenotype of the cells. It is 
known that NK cells exhibit different phenotypes with diverse properties.  If the mature phenotypes of 
NK cells can be increased it is possible that sufficient effector functions against M.tb can be secured.  
 
It would be of interest to compare the effector functions of NK cells between healthy controls and 
active TB cases. Finally, HLA class I genotypes should be incorporated and more samples should be 
included for each group.  Cytokine expression between the different NK cell subsets can also be further 
investigated.  
 
4.6 Concluding remarks  
 
A case-control association study found that an overexpression of aKIR genes may protect against TB 
disease development.  To functionally validate this, the mycobacterial killing efficiency of NK cells 
from individuals with five or more aKIRs were compared to individuals with less than five aKIRs.  
Even though the exact protective role of NK cells against M.tb due to the number of aKIRs expressed 
on their surfaces is still unclear, the protocols generated in this thesis can be used by follow up studies.  
Furthermore this pilot study is the first to incorporate the number of aKIRs while investigating the 
effector functions of NK cells against mycobacteria.  Additionally, this is one of the few studies that 
investigated the antimicrobial defences of NK cells in direct response to mycobacteria.  Identifying 
genes that confer susceptibility to TB disease can be used in developing personalised medicine.  
Furthermore knowledge of the effector functions of NK cells during M.tb infection can be used to 
modify NK cells and may contribute to developing novel strategies to improve immunosurveillance.  
Future work will include repeating this study with bigger sample size and determining the effect of 
indirect mycobacterial stimulations on NK cell phenotype.  
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Add 800mL dH20 
Adjust the pH to 8.0 with concentrated HCl 
Make up 1L with dH20 
Autoclave for 20 min at 121°C and store at RT 
 
Reagent A  
10mM Tris-HCl  
320mM Sucrose 
5mM MgCl2 
1% (v/v) Triton x-100, pH 8.0 
Combine reagents in 80% of the volume required, mix to dissolve 
Adjust pH to 8.0 using 40% (w/v) NaOH 
Autoclave aliquots at 121°C for 15 min 
 
2. KIR genotyping  
1% Agarose gel 
1g agarose  
100mL (1x) SB Buffer  
Microwave for 2-3 min  
add 5µL ethidium bromide (10mg/mL) when temperature reaches ±55°C 
 
Loading dye  
5 µL Cresol loading dye  
 
3. PBMC isolations  
Phosphate buffered saline (PBS)  
1 tablet PBS 
dH20 up to final volume of 200mL  
Autoclave for 20 min at 121°C and store at 4°C 
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4. Cryopreservation  
Cryomedia 
10% DMSO  
45mL FBS  
Filter 
*Do not freeze & thaw FBS more than once  
 
Thawing media  
445mL RPMI-1640 
50mL FBS  
5mL Penicillin Streptomycin 
Filter FBS and Penicillin Streptomycin  
 
5. NK cell isolations  
0.5M EDTA 
93.06g EDTA  
400mL dH20 
Adjust pH to 8.0 using ± 10g NaOH pellets  
Make up to 500mL with dH20 
Autoclave at 121°C for 20min and store at RT  
 
Recommended media 
293.4mL PBS  
6mL  FBSS  
0.6mL (1mM EDTA) 
Autoclave PBS at 121°C for 20min, let cool down and add FBS + EDTA  
 
NK cell culture media 
450mLRPMI-1640 
50mL FBS 
50U/mL hIL-2  
Store at 4°C 
 
6. Bacterial culture  
Middelbrook 7H9 medium  
Suspend 4.7g of 7H9 powder in 900mL dH20 (supplemented with 2mL glycerol) 
Autoclave at 121°C for 10 min 
Aseptically add 100mL of Middelbrook OADC Enrichment to medium when cooled 
(45°C) 
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Middelbrook 7H11 Agar plates  
Suspend 19g 7H11 powder in 900mL dH20 (supplemented with 5mL glycerol) 
Autoclave at 121°C for 10 min 
Aseptically add 100mL of Middelbrook OADC to medium when cooled (45°C) 
Aseptically pour in petri dishes and let air dry in hood  
 
7. FACS  
FACS/Staining buffer 




1x PBS  
 
Fixative buffer 
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In order to determine the number of cells per mL, the number of cells in each of the five larger square 
blocks was counted.  The amount of the cells in these five squares was added together and divided by 
five to get an average number of cells for each of the 25 large squares of the central quadrant of the 
haemocytometer.  The average number of cells was subsequently multiplied by 25 to get an estimated 
average number of cells within the large central quadrant.  The formula used to determine the number 
of cells/ml is as follows:  
 
Number of cells/mL = number of cells x dilution factor x 104 (because the depth of the counting 
chamber is 0.1mm) 
 
Cell counting  
Countess™ II FL automated cell counter  






                                                                    B)  𝑇 = 𝐶𝐴 𝑥 𝑉 
 
Cell counted calculation by Countess™ II FL Automated cell counter.  (A) Determining the 
concentration of cells counted, (NA = Live cell counts as displayed by automated reader, D = Dilution 
of cells with trypan Blue). (B) Calculating the total number of cells counted, (V= Resuspension 
volume of cells in cryomedia in mL)                                     
 
Calculation for the stimulations with M.tb H37Rv  
Concentration [ ] = 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝐹𝑈
𝑉𝑜𝑙𝑢𝑚𝑒 (𝑚𝑙) 𝑡ℎ𝑎𝑡 𝑦𝑜𝑢 𝑝𝑙𝑎𝑡𝑒𝑑 𝑋 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
 
 
Number of M.tb H37Rv per NK cells                     
MOI = 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑋 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑤𝑒𝑙𝑙
                                                                  * MOI = 5
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Appendix III 
Antibody titration values 
Table 1A: Fluorophores and their absorption and emission spectra.  
*nm, nanometer 
 
Table 2A: CD3 antibody titration dilution values.  




negative  Dilution 
Ratio 
pos/neg 
CD3 APC-Cy7 7800 136 10 57.4 
CD3 APC-Cy7 7629 120 20 63.6 
CD3 APC-Cy7 7049 93.8 40 75.1 
CD3 APC-Cy7 6474 84.8 80 76.3 
CD3 APC-Cy7 5737 75.8 160 75.7 
 
Table 3A: CD4 antibody titration dilution values. 







CD4 PerCP-Cy55 13701 240 10 57.1 
CD4 PerCP-Cy55 14119 196 20 72.0 
CD4 PerCP-Cy55 14250 169 40 84.3 
CD4 PerCP-Cy55 13956 153 80 91.2 
CD4 PerCP-Cy55 11377 140 160 81.3 
 
Table 4A: CD8 antibody titration dilution values.  







CD8 PE-Cy7 32486 82.2 10 395.2 
CD8 PE-Cy7 44764 74.5 20 600.9 
CD8 PE-Cy7 48021 66.8 40 718.9 
CD8 PE-Cy7 39765 61.6 80 645.5 
CD8 PE-Cy7 27410 50.1 160 547.1 









APC_Cy7 650 595,633,635,647 774 BD FACSCANTO II 
PerCP_Cy5.5 482 488 690 BD FACSCANTO II 
PE_Cy7 496,565 488 774 BD FACSCANTO II 
APC 645 595,633,635,647 660 BD FACSCANTO II 
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Table 5A: CD56 antibody titration dilution values.  







CD56 APC 590 93.8 10 6.3 
CD56 APC 642 86.1 20 7.5 
CD56 APC 839 71.9 40 11.7 
CD56 APC 918 62.9 80 14.6 
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Figure 1A: Graphs showing the overlay of the NK cell counts within each population. Orange, NK cells; 
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Figure 1A continued: Graphs showing the overlay of the NK cell counts within each population. Orange, NK 
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Table 6A: The frequency of the CD3- subset for each sample are indicated in the last column. X indicates that 
data are missing (cells not present).  
Sample name  Subset Name Count Frequency (%) 
Sample 1_NK cells CD3- 18219 74.6% 
Sample 1_Non-NK fraction CD3- 6681 25.3% 
Sample 1_PBMCs  CD3- 3309 14.6% 
Sample 2_NK cells CD3- 3383 86.3% 
Sample 2_Non-NK fraction CD3- 303 87.1% 
Sample 2_PBMCs  CD3- x x 
Sample 3_NK cells CD3- 2290 70.8% 
Sample 3_Non-NK fraction CD3- 819 98.6% 
Sample 3_PBMCs  CD3- 26080 27.2% 
Sample 4_NK cells CD3- 3119 39.6% 
Sample 4_Non-NK fraction CD3- 527 82.1% 
Sample 4_PBMCs  CD3- 3310 14.3% 
Sample 5_NK cells CD3- 3305 73% 
Sample 5_Non-NK fraction CD3- 16139 67.4% 
Sample 5_PBMCs  CD3- 17742 43.1% 
Sample 6_NK cells CD3- 40219 85.6% 
Sample 6_Non-NK fraction CD3- 44491 33.6% 
Sample 6_PBMCs  CD3- 6636 33.1% 
Sample 7_NK cells CD3- 544 50.6% 
Sample 7_Non-NK fraction CD3- 2639 62.5% 
Sample 7_PBMCs  CD3- 9155 14.3% 
Sample 8_NK cells CD3- 32073 68.9% 
Sample 8_Non-NK fraction CD3- 26748 67.1% 
Sample 8_PBMCs  CD3- 18800 46.4% 
Sample 9_NK cells CD3- 41136 87.6% 
Sample 9_Non-NK fraction CD3- 40226 91.5% 
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Sample 9_PBMCs  CD3- 4714 21.8% 
Sample 10_NK cells CD3- 7171 60.7% 
Sample 10_Non-NK fraction CD3- 32645 69.3% 
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Appendix V 
Normal probability plots  
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Appendix VI 
List of suppliers  
Reagents    
EDTA  Thermo Fisher Scientific 
HCl  Sigma-Aldrich 
Agarose  Sigma-Aldrich 
Cresol loading dye  Sigma-Aldrich 
Cryovials  Merck 
PBS  Sigma-Aldrich 
DMSO  Sigma-Aldrich 
FBS  Sigma-Aldrich 
Formaldehyde  Sigma-Aldrich 
RPMI-1640  LONZA Group  
PEN-STREP  Thermo Fisher Scientific 
hIL-2  Merck 
Middelbrook 7H9   Becton Dickson 
Middelbrook 7H11  Becton Dickson 
Glycerol   Sigma-Aldrich 
OADC  BD Bioscience  
Ficoll-plaque plus  Sigma-Aldrich 
Trypan Blue   Thermo Fisher Scientific 
Dnase   Thermo Fisher Scientific 
Universal DNA ladder  Kapa Biosystems  
Kappa Taq readymix  Kapa Biosystems  
Ethidium bromide   Sigma-Aldrich 
   
Kits    
EasySep™Human NK Cell Isolation kit   Stemcell technologies  
Nucleon BACC3™ Genomi DNA extraction kit   GE Healthcare  
Human CD8+ T-cell Magnetic bead Panel   EMD Millipore  
Human Cytokine/chemokine bead Panel  EMD Millipore  
   
Antibodies   
CD3 APC-Cy7  BioLegend  
CD4 PerCP-Cy5.5  BioLegend  
CD8 PE-Cy7  BioLegend  
CD66 APC   BioLegend  
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Equipment   
0.2µm filters   Thermo fisher scientific  
1mL/cc insulin syringe   Supra  
24 well plates  Whitehead Scientific  
37°C Incubator   Merret  
4 Objective Light Microscope   LW Scientific  
5% CO2, 37°C shell lab Incubator   Sheldon manufacturing  
5µm filters  Milex 
96 well plates     Greiner Bio-one  
Automatic plate washer   Bio-Rad  
Centrifuge 5810R   Eppendorf  
Consort electrophoresis power supply ps500xt   Hoffer scientific instruments  
Countess automated cell counter   Thermo Fisher scientific  
Countess loading plates  Thermo Fisher scientific  
Dry block heater  Thermo Fischer Scientific  
EDTA tubes  Kendon Medical supplies  
Eppendorf tubes (1mL, 2mL)   Sigma-Aldrich  
FACS tubes   The Scientific group  
FACSCANTO II   BD Biosciences  
G-box   Syngene  
Gel casting tray   Bio-Rad 
Gloves  Avacare  
Half 90mm petri dishes   Thermo Fisher scientific  
Hypodermic Needles 21GX1       Avacare  
Imperial III water bath   Imperial Scientific works  
Magnet  Stemcell technology  
Magnetic stirrer   Velp Scientific  
Micropore tape   Clicks pharmacy  
Microscope   Nikon instruments Inc  
Mr frosty  Thermo fisher scientific  
Nanodrop ND-1000   Inqaba Biotechnology  
Neubour haemocytometer  Celeromics  
OD reader   WPA Biowave  
Orbital Shaker incubator LM-530   Yih Der  
Parafilm             Sigma-Aldrich 
Pipette tips filtered (10µL,20µL 200µL, 1000µL)   Trefflab  
Pipettes (10µL, 20µL 200µL, 1000µL)  Trefflab  
Sonicator   Branson  
Spinning wheel   Eppendorf  
Syringes   Avacare  
Titer Plate Shaker   Eppendorf 
Vortex whirl Mixer   Stuart equipment  
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Programs    
FlowJo®  https://www.flowjo.com/ 
R version 3.2.4  
https://cran.r-
project.org/bin/windows/base/ 
nmle version 3.1-131  
https://cran.r-
project.org/package=nlme 
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Table 7A: The aKIR genes that were absent/present.  The last column indicates the frequencies of observing 
the amount of aKIRs. 
Sample  2DL4 2DS1 2DS2 2DS3 2DS4 2DS5 3DS1 Total  
Frequency 
(%) 
Sample  2 yes no no no no no no 1  
Sample  3 yes no no no no no no 1  
Sample  4 yes no no no no no no 1 20 
Sample 13 no no no no yes no no 1  
Sample 14 no no no no yes no no 1  
Sample 15 no no no no yes no no 1  
Sample   1 yes no no no no yes no 2  
Sample   5 yes no no no yes no no 2  
Sample  11 yes no no no yes no no 2  
Sample 16 yes no no no yes no no 2 27 
Sample 17 yes no no no yes no no 2  
Sample 19 yes no no no yes no no 2  
Sample 26 yes no no no yes no no 2  
Sample 28 yes no no no yes no no  2  
Sample 12 yes no yes yes no no no 3  
Sample 20 yes no yes no yes no no 3  
Sample 21 no no no yes yes no yes 3  
Sample 22 yes no yes no yes no no 3 27 
Sample 23 yes no no no yes no no 3  
Sample 24 yes no yes no yes no  no 3  
Sample 27 yes no yes no yes no no  3  
Sample 29 yes no no no yes yes no 3  
Sample 18 yes no yes yes yes no no 4  
Sample 25 yes no no no yes yes yes 4 10 
Sample 30 yes no no no yes yes yes 4  
Sample 6 yes no yes yes yes no yes 5  
Sample 8 yes no yes yes no yes yes 5  
Sample 9 yes no yes no yes yes yes 5 17 
Sample 10 yes no yes no yes yes yes 5  
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Table 8A: The total count and frequencies of each gene observed within the cohort (n = 30).  
Gene Absent Present Frequency (%) 
KIR2DL4 4 26 87 
KIR2DS1 29 1 3 
KIR2DS2 20 10 33 
KIR2DS3 24 6 20 
KIR2DS4 6 24 80 
KIR2DS5 22 8 27 
KIR3DS1 22 8 27 
 
Table 9A: KIR gene profiles of the 30 individuals.  





Sample  2 AA yes             1   
Sample  3 AA yes             1 10 
Sample  4 AA yes             1   
Sample 13 AA         yes     1   
Sample 14 AA         yes     1 10 
Sample 15 AA         yes     1   
Sample  1 Bx yes             2 3 
Sample  5 Bx yes       yes     2   
Sample 11 Bx yes       yes     2   
Sample 16 Bx yes       yes     2 23 
Sample 17 Bx yes       yes     2   
Sample 19 Bx yes       yes     2   
Sample 26 Bx yes       yes     2   
Sample 28 Bx yes       yes     2   
Sample 12 Bx yes   yes yes       3 3 
Sample 21 Bx         yes   yes 3 3 
Sample 20 Bx         yes     3   
Sample 22 Bx         yes     3 13 
Sample 24 Bx         yes     3   
Sample 27 Bx         yes     3   
Sample 23 Bx         yes     3 3 
Sample 29 Bx               3 3 
Sample 18 Bx               4 3 
Sample 25 Bx yes             4 7 
Sample 30 Bx yes             4   
Sample 6 Bx yes             5 3 
Sample 8 Bx yes             5 3 
Sample 9 Bx yes             5 
7 
Sample 10 Bx yes             5 
Sample 7 Bx yes             6 3 
*black blocks indicate the gene is present, white blocks indicate gene is absent. Our KIR genotype designations are in 
concordance with that of the Allele Frequency Net Database (AFND; http://www.allellefrequencies.net)229  
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